Reflex release of adrenaline and noradrenaline from the canine adrenal medulla by Ellis, P.
REFLEX RELEASE OF ADRENALINE




THESIS SUBMITTED FOR THE DEGREE OF
DOCTOR OF PHILOSOPHY, UNIVERSITY OF EDINBURGH, 1983.
Declaration
This thesis is entirely my own composition and the work detailed within




The release of catecholamines from the canine adrenal medulla in
response to various stimuli was investigated xin vivo' and vin vitro' to
attempt to answer the following questions
1. Are the catecholamines adrenaline and noradrenaline selectively
released by the canine adrenal medulla?
2. Are the baroreceptor and chemoreceptor reflex responses mediated by
nicotinic and muscarinic receptors respectively?
3. Is there a humoral mechanism involving the anterior pituitary-
adrenocortical axis controlling catecholamine release?
4. Are prostaglandins involved in maintaining adrenal blood flow?
The results in this thesis show:-
1. There is no evidence for selective release of adrenaline or
noradrenaline during either chemoreceptor stimulation, baroreceptor
reflex stimulation or corticotrophin infusion. However, the
nicotinic antagonist, hexamethonium bromide, produced small but
consistent increases in the resting percentage of noradrenaline
relative to adrenaline. This observation is consistent with the
findings of other workers.
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The adrenomedullary response to baroreceptor and chemoreceptor
reflex stimulation is significantly reduced by hexamethonium and,
to a lesser extent, by hyoscine methyl bromide. This suggests that
transmission of both the baroreceptor and chemoreceptor reflex to
the adrenal medulla of the dog consists predominently of nicotinic
receptor activation with a large subsidiary muscarinic component.
Although the distinction between baroreceptor and chemoreceptor
reflex transmission was poor there was some evidence to suggest
selectivity of the baroreceptor reflex for nicotinic receptors and
the chemoreceptor reflex for muscarinic receptors.
There are two components to the response of the adrenal medulla to
carotid body hypoxia. The first is a rapid release of
catecholamines which requires an intact nerve supply to the adrenal
gland but is independent of adrenocortical function. The second is
a delayed release of catecholamines which, in contrast to the rapid
release, requires an intact pituitary-adrenocortical axis, but is
independent of the motor nerves to the gland. Release of
catecholamines from the canine adrenal medulla, in response to
carotid body hypoxia, is therefore controlled by both neural and
humoral mechanisms.
Adrenal blood flow is reduced both at rest and during reflex
stimulation of the adrenal gland by the prostaglandin synthetase
inhibitor, indomethacin. On comparing the resting pressure-flow
curves of a range of dogs I found indomethacin significantly
depressed the curve; therefore indicating prostaglandins do play a
role in maintaining adrenal blood flow. I would further suggest
prostaglandins are released with catecholamines and maintain
adrenal blood flow by opposing their constricting action. This may
also explain why platelet aggregation due to high concentrations of
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The first aspect of catecholamine release from the canine adrenal
medulla we investigated was whether the two catecholamines, adrenaline
and noradrenaline, could be released independently by carotid
baroreceptor and chemoreceptor reflexes, with the dog under either
pentobarbitone or chloralose-urethane anaesthesia.
This study was initiated from the results of earlier work in our
laboratory, by Critchley and UngarC" They tried to answer a similar
question to the one above but compared catecholamine release in
response to baroreceptor and chemoreceptor reflex stimulation in the
cat under pentobarbitone anaesthesia with the dog under
chloralose-urethane anaesthesia. Their results clearly demonstrated
selective release of the two catecholamines in the cat; the
baroreceptor reflex selectively releasing noradrenaline and the
chemoreceptor reflex selectively releasing adrenaline. In the dog
they found no evidence of selective release of either catecholamine in
response to either reflex.
As it is known that anaesthetics can have a marked effect on
catecholamine release from the adrenal medulla (see 'Methods
anaesthesia' and De Schaepdryver (1959)) we did not consider this study
an ideal comparison of dog with cat. In order to ascertain if
Critchley and Ungar's study reflected a true difference between dog
and cat we repeated the study comparing dogs under both types of
anaesthesia.
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Whilst our study, in conjunction with that of Critchley and Ungar,
only provides data comparing dog and cat, we hoped that it might close
the long standing debate of whether adrenaline and noradrenaline are
released independently. On reviewing the literature, we find most
evidence in favour of selective release to come from studies on the
cat (von Euler and Folkow (1953), Folkow and von Euler (1954), Duner
(1953)) and most evidence against to come from studies on the dog
(Malmejac (1964)). This would suggest a species difference as the
simplest answer to the debate.
There is some evidence suggesting selective release in the dog, but in
all cases the change in the noradrenaline:adrenaline ratio is small.
Work done using muscarinic and nicotinic agonists and antagonists has
revealed the following
Rapela and Houssay (1952)
Nicotine selectively releases adrenaline relative to noradrenaline.
Kayaalp and Mclsaac (1968)
Methacholine selectively releases noradrenaline relative to
adrenaline.
De Schaepdryver (1959)
Acetylcholine, in the presence of atropine, selectively releases
adrenaline relative to noradrenaline.
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This would imply the release of noradrenaline and adrenaline may be
mediated by muscarinic and nicotinic receptors respectively, but as
the changes observed are all small neither catecholamine can be under
the sole control of any one mechanism. The main evidence against
selective release by muscarinic and nicotinic agonists comes from our
own laboratory (Critchley (1976)). However, all the evidence in
favour of selective release comes from 7in vivo' studies in the dog
whereas Critchley's evidence against selective release is based on 'in
vitro' studies in isolated perfused adrenal glands; a very artificial
situation. I therefore considered this a possibility and measured
catecholamine levels before and after blockade by the nicotinic and
muscarinic antagonists, hexamethonium bromide and (-) hyoscine methyl
bromide, in dogs under pentobarbitone and chloralose-urethane
anaesthesia.
Other evidence suggests selective release of noradrenaline occurs with
increasing frequency of splanchnic nerve stimulation, (Klepping
(1956), Malmejac (1957), Rapela (1956), Rapela and Covian (1954)).
However, an equal amount of evidence has been produced suggesting
either no change or even a decrease in the ratio of noradrenaline:
adrenaline (Lund (1951), Malmejac (1964), Mirkin (1961)). As changes
in the ratio are small and variable, evidence in favour of selective
release is poor. However, the different techniques used by workers
may be responsible for the differing results and different patterns of
nerve stimulation may produce selective release of one catecholamine
or the other. This theory in conjunction with the muscarinic and
nicotinic work is discussed further in association with my own
findings (see Discussion of Effects of cholinergic antagonists on the
reflex release of catecholamines from the canine adrenal gland').
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On the other hand, no evidence has been produced to support selective
release during baroreceptor or chemoreceptor reflex stimulation. (De
Schaepdryver (1959), Malmejac (1964), Critchley (1976)). This is not
(I9b0)
the case in the cat. Anichkov et alC1 compared the effects of carotid
occlusion with cyanide injection, and found carotid occlusion produced
a relatively greater vasoconstriction in a denervated hind limb
whereas cyanide injection produced relatively greater constriction of
a denervated nictitating membrane. For this reason Critchley and
Ungar chose to investigate the release of adrenaline and noradrenaline
in response to the baroreceptor and chemoreceptor reflex in cats and
dogs.
For direct comparison with Critchley and Ungar's results we used the
same adrenomedullary stimuli. For this we used a system which enabled
us to independently alter the carotid perfusion pressure or the gas
tensions of the blood perfusing the isolated carotid bifurcations.
Stimulation to the carotid baroreceptors was reduced for periods of
one minute and the chemoreceptors stimulated for one and a half
minutes to produce roughly similar releases of catecholamines
(adrenaline and noradrenaline) from the adrenal medulla.
As I have mentioned, there is some evidence to suggest nicotinic and
muscarinic agonists may selectively release adrenaline and
noradrenaline respectively from the canine adrenal medulla. The
evidence supporting selective release in the cat is much firmer,
(Douglas and Poisner (1965), Rubin and Miele (1968), Critchley
(1976)). In the case of the cat however, adrenaline release is
favoured by muscarinic stimulation and noradrenaline release by
nicotinic
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stimulation. These results,combined with the studies of Anichkov et
091k,
al. (1960) and Critchley and Ungar^ reveal that both baroreceptor
reflex stimulation and nicotinic agonists release noradrenaline from
the cat adrenal medulla, whereas chemoreceptor reflex stimulation and
muscarinic agonists release adrenaline. We may then hypothesise that
the baroreceptor reflex in the cat is mediated by nicotinic receptors
whereas the chemoreceptor reflex is mediated by muscarinic receptors.
Support for this hypothesis comes from Critchley and Ungar's work, in
which hexamethonium was found to abolish catecholamine release in
response to baroreceptor reflex stimulation, while the response to
chemoreceptor reflex stimulation was unaltered. We wondered therefore
if a similar, or even opposite, situation exists in the dog. A
physiological role for the nicotinic and muscarinic receptors, known
to be present, being mediation of the baroreceptor or chemoreceptor
reflex. We therefore investigated the response of the canine adrenal
medulla to baroreceptor and chemoreceptor reflex stimulation, before
and after the nicotinic and muscarinic antagonists hexamethonium
bromide and (-)hyoscine methyl bromide. This also allowed us to
investigate the effects of muscarinic and nicotinic antagonists on the
release of noradrenaline relative to adrenaline from the canine
adrenal medulla '_in vivo' .
During a routine experiment by Ungar and Critchley, in which the
release of catecholamines in response to chemoreceptor stimulation in
the dog was being investigated, the sodium dithionite infusion into
the carotid perfusion loop was inadvertently left on for 10 minutes.
This was later found to have produced a marked release of
catecholamines from the adrenal medulla which outlasted the stimulus
by more than 30 minutes. This would suggest that prolonged carotid
body hypoxia evokes a humoral response which induces catecholamine
release. The most likely source of a hormone acting on the adrenal
medulla is obviously the adrenal cortex which completely surrounds the
medulla in the dog. The cortex itself is under hormonal control from
the anterior pituitary by corticotrophin and, as carotid body hypoxia
has been shown to release corticotrophin from the anterior pituitary
et al
(Anichkov^(T960), Marotta (1972)), it is reasonable to suppose that
corticosteroids released from the cortex, by corticotrophin, may
mediate the hormonally-induced catecholamine release.
It is known that high concentrations of glucocorticoids are necessary
to maintain the synthesis of the enzyme PNMT, (phenylethanolamine-N-
methyl transferase), which converts noradrenaline to adrenaline in the
adrenal medulla (Pohorecky and Wurtman (1971)). It is this action of
the corticosteroids which has most interested researchers, and any
possible effect of corticosteroids on catecholamine release, rather
than synthesis, has not been considered. However the work of Wurtman
et_ al_. (1968) contains several pieces of information which support the
involvement of the pituitary-adrenocortical axis in modulating
catecholamine release and encouraged us to investigate this
09b8)
possibility. The work of Wurtman ej: al_. is discussed later along with
our own results.
To investigate the possible involvement of the pituitary-adreno¬
cortical axis in the release of catecholamines we studied
catecholamine release in response to prolonged carotid body hypoxia in
control dogs, dogs with denervated left adrenal glands and dogs
pretreated with cycloheximide, a drug known to inhibit corticosteroid
release in response to corticotrophin (Garren et al. (1965)). If the
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release of catecholamines is Immorally mediated then denervation
should not affect release. If the pituitary-adrenocortical axis is
involved then cycloheximide should abolish release. In addition to
this study we also looked at the effects of Synacthen, a synthetic
analogue of corticotrophin, on adrenomedullary release of
catecholamines.
This has summarised the areas we intended to investigate during this
research project. However, a chance finding opened out an alternative
area of work which we also had the opportunity to investigate. One
of the worst problems we encountered in studying the reflex release of
adrenaline and noradrenaline from the canine adrenal medulla was large
and maintained falls in systemic blood pressure following laparotomy.
This is not generally considered a problem but the animals we were
compelled to use, for financial reasons, were invariably in very poor
condition. The animals used were mongrels coming largely from collie
stock and it is possible that the breed of dog may have been partly
responsible for the problems we experienced. To overcome the fall in
blood pressure occurring following laparotomy we administered
indomethacin, a prostaglandin synthetase inhibitor, as Terragno et al.
(1977) have shown laparotomy releases prostaglandins, and that
indomethacin given after laparotomy restores the blood pressure. We
found indomethacin prevented the fall in blood pressure but in
addition it also reduced adrenal blood flow. We therefore
investigated the effect of indomethacin on adrenal blood flow and
catecholamine release. For supportive data we investigated the
effects of prostaglandin in the isolated perfused canine adrenal
gland.
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Our findings from these four areas of research,
A) Selective release of adrenaline and noradrenaline from the canine
adrenal medulla.
B) Effects of cholinergic antagonists on the reflex release of
catecholamines from the canine adrenal.
C) The role of the pituitary-adrenocortical axis in reflex responses
of the adrenal medulla of the dog.
D) Effects of indomethacin on blood pressure, catecholamine release
and adrenal blood flow in the anaesthetised, laparotomised dog.
are presented and discussed later.
The term 'catecholamine' in this thesis refers only to adrenaline and
noradrenaline.
Parts of this work are published and copies of publications are
included in the back of this thesis.
In the introduction I have outlined the work to be covered by this
thesis and have described some of the findings which prompted the
work. The physiology and pharmacology of the adrenal gland, relevant
to this thesis, is discussed in relation to my own findings in the
discussion sections. However, for a comprehensive review of all the
physiology, pharmacology and biochemistry of the adrenal gland I refer
the reader to 'Handbook of Physiology (1975) Section 7 Endocrinology
VI Adrenal Gland' and to the very recent review article 'The
regulation of the adrenal medulla' by Ungar and Phillips •
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I have however presented very brief summaries of the carotid
baroreceptors and chemoreceptors concerning their relevance to the
experimental methods I have used. I have also outlined the anatomy,
innervation and blood supply of the adrenal gland before going on to
consider the techniques available for the assay of catecholamines.
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Arterial Baroreceptors
The baroreceptors are located in the carotid sinus, aortic arch,
thyrocarotid junction and the cardiopulmonary area. They are stretch
receptors which are excited by the expansion of the vessel wall, which
is in turn controlled by blood pressure. With a normal blood pressure
the baroreceptors exert a tonic inhibitory influence on sympathetic
drive to the heart, blood vessels and the adrenal medulla. As blood
pressure falls so does this inhibitory influence, accompanied by a
corresponding increase in sympathetic activity resulting, among other
things, in increased adrenomedullary secretion of catecholamines
(Heymans and Neil (1958)).
The most accessible arterial baroreceptors are those located in the
carotid sinus. For this reason we isolated an area around the
carotid sinus and controlled the pressure within it. Apart from
being the most accessible of the baroreceptor sites, the carotid sinus
and the carotid body, which is densely populated with arterial
chemoreceptors, may be isolated together in the same artificial
perfusion loop.
To stimulate catecholamine release from the adrenal medulla we lower
the perfusion pressure of the carotid sinus. To avoid referring
separately to inhibition of baroreceptors and stimulation of
chemoreceptors we have described the lowering of perfusion pressure as
a 'baroreceptor test' and the response as the 'baroreceptor reflex'.




The systemic arterial chemoreceptors are located in the carotid bodies
and in the aortic bodies. They are receptors which are sensitive to
changes in the partial oxygen pressure (P02) of arterial blood and
also to blood flow, but only when the P02 is iow. in addition to the
arterial chemoreceptors there are central chemoreceptors which are
situated in the floor of the fourth ventricle and the medulla
oblongata.
By isolating the carotid bifurcations we are dealing solely with
arterial chemoreceptors. Therefore I use the term chemoreceptor in
this thesis to refer specifically to the chemoreceptors of the carotid
body. The lowering of the P02 of the carotid perfusate is referred to
as a 'chemoreceptor test' and the response as the 'chemoreceptor
reflex'.
For a review of arterial chemoreceptors see 'Arterial Chemoreceptors'
(I9b8)
by R.W. Torrance (Ed. and 'The systemic arterial chemoreceptors' by
M.J. Purves (Ed.)(\975).
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The anatomy of the adrenal gland
The adrenal or suprarenal glands of mammals lie either separate from
or attached to (primates) the superior surface of the kidney, as the
terms adrenal and suprarenal imply. As it is the dog which has been
studied for this thesis the anatomical details to follow will apply
particularly to the dog and the term adrenal applied.
The adrenal glands are small, buff coloured, irregularly shaped
endocrine organs. (3 cm x 1 cm x 0.5 cm in the dog). The right
adrenal gland lies between the venacava and liver ventrally and the
abdominal wall dorsally; its lateral border lying opposite the
superior half of the right kidney. The left adrenal gland lies
between the aorta and the medial border of the superior half of the
left kidney, touching the abdominal wall dorsally. As seen with the
kidneys the left adrenal gland lies inferior to the right and is
considerably more accessible for dissection and cannulation
procedures. Therefore, the left adrenal gland has been favoured by us
and others for investigation _in vivo.
The adrenal gland is composed of an outer cortex and an inner medulla
bound by a thin capsule, consisting largely of connective tissue. The
cortex, developed from cells of the coelomic mesothelium, is
sub-divided into three clearly distinguishable zones, the zonae
glomerulosa, fasiculata and reticularis. Although some conflicting
evidence exists , the zona glomerulosa probably produces the
mineralocorticoids, desoxycorticosterone and aldosterone, which
maintain the electrolyte level in extracellular fluids. The function
of this zone is dependent only on sodium and potassium balance and is
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independent of the hypothalamus and pituitary. The zona fasiculata
and zona reticularis produce glucocorticoids, the main ones being
corticosterone, hydrocortisone (Cortisol) and cortisone. (The zona
fasiculata is thought to be non-secretory, acting as a store of
steroid precursors for the zona reticularis). The glucocorticoids
have many functions, among them are facilitation of protein catabolism
and gluconeogenesis, destruction of lymphocytes and release of gamma
globulins (increased immune response) and inhibition of cellular and
fibrous proliferation (anti-inflammatory). The function of these two
zones is closely controlled by the hypothalamus (corticotrophin
releasing factor, CRF) and the pituitary, (adrenocorticotrophic
hormone, ACTH).
The adrenal medulla, in contrast to the cortex, is developed from
ectodermal cells derived from the neural crest. The medulla is
red/brown in colour, making it clearly distinguishable from the pale
yellow cortex surrounding it. The medulla is composed of a spongework
of large polygonal cells, separated by sinusoidal vessels. The cells
of the medulla are granular, the granules being evenly distributed in
the cytoplasm and containing the catecholamines of the adrenal gland
(Hillarp and Nilsson, (1953, 1954) ; Blaschko and Welch (1953)).
The medullary cells stain brown with fixatives containing chromium
salts, due to an oxidation and polymerisation of the catecholamines.
The cells are therefore referred to as chromaffin cells (Kohn 1898) or
phaeocromocytes (Poll 1906).
The adrenal medulla was first shown to contain noradrenaline as well
as adrenaline by Holtz _et_ aT. (1947). Since then, noradrenaline has
been identified in the adrenal glands of many different species in
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varying proportions. After the discovery of noradrenaline in the
(1250 > 195 V}
adrenal medulla
5 Bander'} using classical staining techniques, was able
to show two types of medullary cell present in the adrenal glands of
(1950>19SI^
dogs, cats and mice. Bander^proposed that the two cell types were
related to the production of adrenaline and noradrenaline. Support
for this proposal came from Eranko (1952) who demonstrated acid
phosphatase positive (adrenaline) and acid phosphatase negative
(noradrenaline) cell types in the adrenal medulla. Eranko (1954,
1955, 1958) and Hillarp and Hokfelt (1954) then went on to confirm
that there were indeed separate adrenaline and noradrenaline
(1950 > \95 4)
containing cells in the medulla. Bander'sA original proposal was
validated but it was later shown by Eranko and Palkama (1959) that the
(1950, \95L+)
differential staining seen by BanderA^was dependent only on the
concentration of catecholamines present and not on the type.
In ruminants, as distinct from other domestic animals, two separate
zones are found in the adrenal medulla. An outer zone which staini
dark brown with chromium salts and produces adrenaline and an inner
zone which stains yellowish and produces noradrenaline. This zonation
occurs as a result of conversion of noradrenaline to adrenaline
requiring the enzyme phenylethanolamine-N-methyl-transferase (PNMT).
PNMT is dependent on the high concentration of adrenocorticosteroids
for its activity and the dark outer zone reflects the area supplied
with blood from the adrenal cortex.
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Innervation of the adrenal gland
The adrenal medulla can properly be regarded as a specialised ganglion
of the sympathetic nervous system and the secretory chromaffin cells
are richly innervated by cholinergic preganglionic sympathetic nerve
fibres derived from the lower thoracic segments of the spinal cord.
The main innervation comes from the greater splanchnic nerve which
usually leaves the sympathetic trunk at the twelfth thoracic
sympathetic ganglion. It varies in its origin, however, from the
e
eleventh thoracic to the first lumbar ganglion. The largest of the
splanchnic nerves, it divides into many branches on approaching the
dorsum of the adrenal gland. Some of these end in small adrenal
ganglia, others enter the gland directly, while the identity of others
is lost in the coeliac plexus. A minor contribution to the
innervation of the adrenal medulla comes from the lesser splanchnic
nerves of which there are generally two, usually leaving the
thirteenth thoracic and first lumbar sympathetic ganglia. Frequently
these ganglia are fused, conversely they may be widely separated. The
lesser splanchnic nerves run to the dorsum of the adrenal gland where
they branch and become part of the adrenal plexus.
Teitelbaum (1934) suggested the possibility of a vagal contribution to
the innervation of the adrenal gland but electrophysiological
experiments have not been able to support this. Some preganglionic
vagal fibres are dispersed in the adrenal plexus but do not synapse
there and in the main go on to innervate the small intestine via the
superior mesenteric ganglion.
No nerve supply to the adrenal cortex has been demonstrated.
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Blood Supply to the Adrenal Gland
The adrenal gland derives its blood supply from many very small
adrenal arteries which originate from the nearby large arteries,
usually the renal artery, inferior phrenic artery and aorta. The
vessels form a capsular plexus in the adrenal gland from which
capillary vessels pass centripetally between and around the columns of
cortical cells. A few arterioles pass deep into the cortex (arteriae
corticis) or the medulla (arteriae medullae) before breaking up to
form capillaries. Thus, some blood can reach the adrenal medulla
without first passing through the capillaries of the cortex. Blood
then flows between the chromaffin cells of the medulla and is
collected in the venae medullae which fuse to form the adrenal vein.
On leaving the gland the adrenal vein fuses almost immediately with
either the renal vein or the inferior vena cava.
The existence of two pathways to the adrenal medulla has led to
speculation as to whether the blood supply via the cortical
capillaries can be adjusted to regulate the concentration of
glucorticoids bathing the adrenal medullary cells. In support of this
Symington (1962) has described smooth muscle bundles flanking the
openings of the cortico-medullary venous sinusoids.
For a review of the blood supply to the adrenal gland see "The Natural
History of the Chromaffin Cell" by R.E. Coupland (\9b5).
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Techniques available for catecholamine assay
Four basic methods are currently employed for the assay of
catecholamines. They are:-
1. Biological assay
(see Gaddum (1959), Vane (1966) and Callingham (1967)).
2. Chemical techniques
These techniques are dependent on the formation of fluorescent
derivatives from catecholamines.
(see Udenfriend (1962), HHggendal (1966) and Callingham (1967)).
3. Electrochemical detection
This is dependent on the 2 electron oxidation of catecholamines to
form o-quinones. This generates a current, proportional to the
concentration, which is measured.
(see Kissinger (1977) and Ryan and Wilson (1979)).
4. Isotope derivative techniques
These depend on enzyme specificity and the formation of radio-
labelled derivatives.
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(see Engelman and Portnoy (1968, 1970) and Passon and Peuler
(1973))
Of these techniques bioassay has changed the least during the last 20
years. In the review of Gaddum (1959), he suggested that, in comparison
to chemical methods, "there is little doubt that as time goes on
biological methods of assay will be less used, but they are still
important and chemical methods will only inspire universal confidence if
they are shown to give the same results as the biological methods."
This prediction has proven to be true with chemical methods now largely
used. However, chemical, fluorimetric, methods have reached the stage
bioassay was at 20 years ago, where little development of the technique
is now taking place. Chemical techniques have reached their limit and
more sensitive methods are being sought for circulating and brain
catecholamines, e.g. isotope derivative techniques and electrochemical
detection.
My requirements of the catecholamine assay are as follows
1. Reasonable sensitivity and specificity; as adrenaline and
noradrenaline are the major catecholamines in adrenal venous blood
and are present in fairly large quantities.
2. Reliability and reproducibility.
3. Good discrimination between adrenaline and noradrenaline.
4. High throughput.
5. Low cost.
6. Simple assay, requiring only one operative.
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I shall briefly discuss each of the four techniques with these
requirements in mind.
Bioassay
The sensitivity of most bioassay techniques is good, e.g. less than lng
of adrenaline or noradrenaline (Booker, (1959)). However, the
specificity is often very poor and many substances will interfere.
These substances may have a catecholamine like action on the tissue
themselves or may potentiate or attenuate the effects of catecholamines,
e.g. 5-hydroxytryptamine potentiates the vasoconstriction caused by
catecholamines in the rabbit ear artery. (De la Lande and Harvey,
(1965)).
The best known preparation for discriminating between adrenaline and
noradrenaline is the isolated rat uterus pretreated with stilboestrol.
(Gaddum, Peart and Vogt, (1949)).- This preparation is about 100,000
times less sensitive to noradrenaline than adrenaline. An honours
course practical conducted by the University of Edinburgh is the
differential assay of adrenaline and noradrenaline using the superfused
rat stomach strip in series with the rat uterus. By comparing the
reactions of the two tissues to the unknown mixture with the reactions
to adrenaline and noradrenaline, the proportions of each in the mixture
can be calculated by solving a pair of simultaneous equations. On
testing standard mixtures of adrenaline and noradrenaline the technique
was only able to xroughly' determine the concentrations of adrenaline
and noradrenaline. This was concluded from several assays in which
reliability and reproducibility also proved poor (possibly due to
unfamiliarity of the students with the technique).
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Bioassay is certainly cheap and easy and does have a high throughput.
However, in view of the other considerations bioassay has not been used.
The best use of bioassay for the assay of adrenal venous blood would be
von-line', i.e. Cascade superfusion of tissues directly with adrenal
venous blood. Catecholamine secretion would therefore be determined
independent of any changes in adrenal blood flow. In addition, owing to
the high concentrations of catecholamines, the blood could be diluted as
it leaves the gland and the interference produced by other substances
disregarded. An von-line' superfusion was not attempted owing to
limited man-power. However, if several demonstrators were available,
this could make a very interesting experiment for teaching purposes.
Chemical techniques
The fluorimetric estimation of catecholamines fulfils all of my
requirements and is the method of choice. However, many variations of
this method exist. The selection and modification of techniques used is
discussed later.
Electrochemical detection
Electrochemical detection used in conjunction with high pressure liquid
chromatography (HPLC) has been gaining popularity since its first
practical application in 1973; the assay of catecholamines in brain
tissue, (Kissinger et al, (1973)). Following this initial publication,
liquid chromatography with electrochemical detection (LCEC) has been
applied to a wide variety of problems, involving the trace detection of
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easily oxidised (or reduced) substances; among them catecholamines in
urine (e.g. Kissinger et al, (1975)) and plasma, (e.g. Hallman et al,
(1978)).
The fundamental technique in electrochemical detection is voltammetry.
In this process, an electrode is polarised (held at a fixed potential
with respect to a reference electrode) at a potential at which a desired
chemical reaction occurs; in this case the two electron oxidation of
adrenaline and noradrenaline to o-quinones.
e.g.
The resulting current which flows "in the circuit is dependent upon the
rate of the chemical reaction taking place at the electrode surface.
Since the rate is governed by the concentration of the substance taking
part in the reaction, the measured current is proportional to
concentration, i.e. 'the current is a function of concentration at a
fixed potential. When using electrochemical detection, in which the
solution flows continuously through the detector cell rather than
remaining stationary, as in voltammetry, it is essential the flow rate
remains absolutely constant. This ensures the resulting peak in the
current signal is directly proportional to concentration and not due to
changes in flow.
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The equipment required for LCEC is expensive. Even being fortunate
working in a department which possesses a good constant flow HPLC
machine, the commercially available electrochemical detector and
potentiostat-amplifier will still cost between £ 450 and £2,000 (May 1979
price lists - Anachem Ltd. and EDT Research). This would place this
technique beyond our means.However, many investigators are using their
own vhome-made' detectors and amplifiers, for which methods of
construction are published. (Cost is about £20). In view of this and
A
the reported high sensitivity, simplicity and low running costs of the
method I decided to further explore the LCEC technique - I visited
Dr. Sharman of the A.R.C. Research Institute, Babraham who routinely
uses LCEC for the assay of catecholamines and their metabolites in brain
tissue. Whilst not convinced the technique was any better than
fluorimetry for the assay of adrenal venous catecholamines, he did not
discourage me from attempting it, and provided me with several useful
tips for setting up the assay in Edinburgh.
The apparatus was assembled and tested using standard mixtures of
adrenaline and noradrenaline. (See later for details). The sensitivity
of the method was good, (lOOpg) but in all other requirements the
technique fell short of fluorimetry. Hence, fluorimetry rather than
LCEC was used for the assay of adrenal venous catecholamines.
A full account of my investigation into LCEC is presented later.
Isotope derivative techniques
This technique is currently the most favoured for the assay of
catecholamines in peripheral plasma, especially by clinical departments
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assaying catecholamines in human plasma.
The original double isotope derivative method of Engeiman et al (1968,
1970) was considered a major methodological advance in the field of
catecholamine analysis. The method is based on the enzymatic conversion
of catecholamines with S-adenosyl-L-methionine.
14 14
(methyl [ C-SAM) and catechol-O-methyltransferase to their
3-0-methylated derivatives. However, the precision of this assay was
unsatisfactory and the adrenaline concentrations in human plasma were at
the detection limit of the assay. Passon and Peuler (1973) introduced
an important modification of this method, the single isotope derivative
3
method, by using H^C-SAM which has a considerably higher specific
14
activity than C-SAM. This resulted in a 10-fold improvement of the
assay sensitivity so that the sample volume could be reduced from 10ml
to less than 1ml plasma. The losses were corrected for by use of
internal standards.
The single isotope derivative method for measuring catecholamines in
plasma is now the technique generally used but does exist in many
modified forms, e.g. da Prada and Ztircher (1976), Peuler and Johnson
(1977), Nagel and Schllmann (1980), Bosak et al (1980).
The two major steps in the radioenzymatic catecholamine assay are
1. conversion of adrenaline and noradrenaline to metanephrine and
normetanephrine respectively, by catechol-O-methyltransferase
3
(COMT) using H^C-SAM as the methyl donor and,
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2. subsequent oxidation of the 3-0-methyl derivatives to vanillin, by
either sodium periodate or ammonium hydroxide, e.g.
R = CH3 ADRENALINE "METANEPHRINE VANILLIN
R = H NORADRENALINE NORMETANEPHRINE
As the reagents for this technique are very expensive and all samples
are done in duplicate, one sample used for the addition of internal
standards, the cost exceeds £2 per sample. This precludes us from even
considering this technique for our purpose. Therefore, rather than
discussing all the possible modifications I have presented a typical
working protocol (taken from Bosak et al, 1980) which outlines the
procedures involved and demonstrates the slow, tedious nature of this
technique
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extraction with diethyl ether
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measurement of radioactivity ( H)
In a recent publication, (Uchikura et al_ (1981)), an attractive
modification of the method has been described, using ion-pair liquid
chromatography to separate the radio-labelled 3 and 4-0-methylated
derivatives. This method avoids the tedious and cumbersome
manipulations of periodate oxidation, solvent extraction and thin-layer
chromatography whilst still providing an accurate and sensitive method
for the determination of catecholamines in blood. This method was not
published when I established my assay but the high cost would still have




Investigation of Electrochemical Detection with High
Pressure Liquid Chromatography for the assay of
catecholamines
A brief account of the principles of electrochemical detection is
already presented. (see xTechniques available for catecholamine
assay'). For a fuller account Kissinger, 1977 and Ryan and Wilson 1979
are recommended.
Equipment
1. High pressure liquid chromatography (HPLC)
Two types of chromatography were evaluated,
a) Cation exchange chromatography, for which a commercial
xPartisil SCX' (strong cation exchange) column was used. The
eluant is an acetate-citrate buffer (pH 5.2) which is prepared
from 5.75g citric acid (monohydrate), 6.8g sodium
acetate. 3^0, 1.05ml glacial acetic acid and 2.4g sodium
hydroxide diluted to 1 litre. (see Keller et al 1976). The
eluant is pumped at a constant rate of 0.5ml/min.
b) Reverse-phase (soap) chromatography, for which a metal column
packed with ODS/TMS silica was used. The eluant in this case
comprises 50mg sodium lauryl sulphate (SLS) dissolved in a
solution of 600ml. 0.1M citric acid and 320ml of 0.1M disodium
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monohydrogen orthophosphate. The eluant is taken from
Kissinger and Riggin (1977) with SLS used as the detergent.
The eluant is pumped at a constant rate of 0.5ml/min.
The detergent used in Nsoap' chromatography is absorbed by the
reverse-phase surface to form a layer which in some ways is akin to
an ion-exchanger.
For this reason the column is primed with eluant for some time
before attempting to run samples. SLS is chosen as the detergent
as it can form an ion-pair with the ionised form of the solute
(catecholamines). To ensure that the catecholamines are in the
preferred ionic form the pH of the solution is made acidic. Thus,
for catecholamines, an acidic eluant containing a cationic
detergent, as above, is generally used.
A good review of the separation of catecholamines by HPLC is given
by Knox and Jurand, (1976), of the Wolfson Liquid Chromatography
Unit, University of Edinburgh.
2. Detector electrode
The detector electrode holder, or block, made according to the
method of Kissinger et al,(l973), is connected to the outflow of the
HPLC column (see figure 1). The electrode itself is made of
graphite paste which is prepared by thoroughly mixing 3.25g of
graphite (high purity - supplied by Dr. Sharman) with 1.75g of Dow
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Figure 1 A schematic representation of the thin-layer electrochemical detector used






(Kissinger et aj, 1973)
Detector Electrode
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Corning high vacuum silicone grease. The graphite paste is then
tightly packed into the cavity around the copper wire of the
detector block and left slightly proud. The final smooth surface
is formed by rubbing the block on the surface of a computer index
card laid on glass (this ensures an even surface). The smoother
the surface of the electrode the less the electrical noise.
3. Reference and Auxiliary electrodes
In addition to a detector electrode one other electrode is required
so that an electrical circuit can be completed. In practice it is
usual to use two additional electrodes; a reference and an
auxiliary electrode. The auxiliary electrode is included to ensure
that no current flows through the reference electrode, ensuring a
constant potential is applied between the detector electrode and
the reference electrode. Without the auxiliary electrode the
reference electrode must conduct current flowing in the cell,
therefore the potential of the reference electrode cannot be truly
constant. Also, if the resistance of the solution in the cell is
high, a potential drop will occur at the electrode/solution
interface. The reference electrode used was a commercial
vsaturated calomel electrode' and the auxiliary electrode simply an
inert metal outflow tube from the reference electrode cell. The
reference electrode cell and holder are constructed from a 10ml




A schematic of the potentiostat and current amplifier is shown in
figure 2. This was constructed by Mr. P. Whelpdale of the
Department of Pharmacology, University of Edinburgh and is a
modification of the system used by Keller et al (1976).
The potential of -15V is applied for all catecholamine work but can
be reversed to +15V if reduction reactions are involved. The
potential control is adjusted until the detector lead is +0.5V with
respect to the reference lead. A higher potential than this will
increase background current whereas a lower potential will not be
sufficient to oxidise the catecholamines and will result in reduced
sensitivity.
When connecting the electrodes it is imperative that the reference
and auxiliary leads be connected before the detector lead. Failure
to do this will result in destruction of the electrode surface
giving a very noisy signal, necessitating repacking of the
electrode.
5. Ultra-violet absorption spectrometer
To identify the time course of catecholamine elution and column
characteristics an ultra-violet absorption spectrometer with a
built in flow cell was coupled onto the column in place of the
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Figure2Potentiostat—AmplifierCircuit
0.02/uF REC—OutputtoRec rder S—ensitivitySwitch
electrochemical detector. This also provided an alternative
detector with which to compare the system under test.
Setting-up procedure
1. The eluant is vacuum deaerated before use and is kept on a hotplate
(45°C) to ensure minimum bubble development in the detector.
2. A coil of 1/16" (o.d.) teflon tubing is connected between the
constant flow pump and the column to dampen any oscillations in
flow. If this is omitted the baseline will resemble a sine wave
pulsing in time with the pump. - This clearly demonstrates the
dependence of the detector on a constant flow.
3. The column is primed with eluant at lml/min. for 2 hours to ensure
stable conditions within the column (particularly when ^soap'
chromatography is being used).-
4. The electrochemical cell is filled with eluant from a syringe
before attaching it to the column. This prevents bubbles from
becoming trapped in the detector. If bubbles are present then
serious vnoise' problems will occur; the bubbles must be removed
before continuing.
5. Flow is reduced to 0.5ml/min.
6. The reference cell is connected and the outflow run to waste.
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7. The potentiostat-amplifier is connected to the 3 electrodes; the
detector electrode being connected last.
8. The electrode is left for up to 5 hours to stabilize to low
residual currents. When used electrodes are replaced in the system
the stabilization time is much less, however, with reused
electrodes the noise level increases significantly. Ideally the
electrode should be set up, stabilized and not removed from the
set-up until replacement is required (normally after about 3 months
of continuous usage).
9. All standards of adrenaline and noradrenaline are made up and
injected in 10 Si HC1.
Results
1. Type of chromatography
Both cation exchange and soap chromatography separated the
catecholamines adrenaline and noradrenaline completely. However,
under the conditions described the separation was better using soap
chromatography. In addition, dopamine is separated from adrenaline
using soap chromatography but not by cation exchange
chromatography.
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Figure 3 Tracing of a chromatograph obtained using SOAP Chromatography
with electrochemical detection.
NA
Chromatograph of a 10>ul injection containing 500 pg of noradrenaline (NA),
adrenaline (A) and dopamine (D).
(Solvent Front = S.F.)
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Figure 3 is an example of a chromatograph obtained using soap
chromatography with electrochemical detection.
2. Limit of sensitivity
Three different detectors were evaluated for their limit of
sensitivity, i.e. The lowest concentration of adrenaline and
noradrenaline in a standard mixture containing equal concentrations
of each which consistently gives peak heights significantly greater
than the background noise.
a) Ultra-violet absorption:- As expected this produced a poor
limit of sensitivity, only 20ng.
b) Electrochemical detection (Home-made using a carbon paste
electrode):- lOOpg could be detected by the better made
electrodes but most could only cope with 200-300pg.
c) Electrochemical detection (EDT Research glassy-carbon
electrode):- Replacing the carbon paste electrode with a
commercial glassy-carbon electrode caused the sensitivity to
fall with the limit being about 2ng. EDT Research claim
limits well below 500pg for clean catecholamine standards;
however, a representative of the company was unable to
substantiate these claims using his equipment in our
laboratory. In fact, using the EDT potentiostatic control
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unit (£1,500) rather than our own (£15) decreased sensitivity
further; the limit rising to 5ng.
3. Linearity
The assay was tested over the range lOOpg to lOjug adrenaline and
noradrenaline and found to be linear.
4. Specificity
Electrochemical detection is not itself a highly specific assay as
several compounds will oxidise at the applied potential. However,
using HPLC in conjunction with electrochemical detection results in
a very selective assay.
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Discussion of problems arising when using this assay for
the determination of adrenaline and noradrenaline in adrenal
venous blood
This assay technique is used for the assay of catecholamines in blood
(Hallman et al 1978) and therefore any problems which may arise with the
assay per se can be overcome. However, what interested me was the
problems this assay would create for me personally compared to any
alternative techniques, especially fluorimetry.
The assay itself would fulfil all my original requirements with the
sensitivity better and the throughput perhaps a little lower than that
desired. I have not designed any purification and extraction procedures
to preceed the assay but I do envisage one potential problem:- The
department does not allow strong acids to be used with the HPLC machine,
i.e. "the catecholamines would have to be prepared finally in weak acid.
This would result in a dilution being necessary and sensitivity lost.
Boric acid is not suitable for chromatography so my extraction technique
for fluorimetry would not be of any use here. Other extraction
procedures use hydrochloric acid to elute catecholamines from strong
cation exchange resins, e.g. 4mls of IN HC1 elutes from Amberlite CG-120
(see xNotes on catecholamine assay'). If this eluant was then diluted
to 0.1N the sample would be contained in 40mls. The maximum volume I
can inject is lOOpl i.e. 1/400th of the sample is assayed and with a
sensitivity limit of 500pg the sample limit would be 200ng. This is
well below the sensitivity of most other techniques.
- 46 -
In addition to this the HPLC machine is required by other users and at
most I could hope for three days of uninterrupted use. This would
necessitate using a new electrode each time, resulting in varying
sensitivities between batches and many hours spent in preparation and
setting-up.
As I could not obtain an HPLC for my exclusive use, and the fluorimetric
assay (which was developed in parallel with this) appeared to fulfil all
requirements perfectly, this technique was not investigated further.
However, if used routinely, in experienced hands this assay could
provide a much simpler alternative than the isotope derivative technique
for the assay of catecholamines in peripheral plasma.
NB:- When investigating this technique I did not enclose the equipment
in a Faraday cage. This resulted in high background noise and the
limit of sensitivity could undoubtedly be lowered by the inclusion
of a Faraday cage in the apparatus.
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Chemical Spectrophotofluorimetric Catecholamine Assay
The objective was to establish a simple and reliable physicochemical
technique for the assay of adrenaline and noradrenaline in adrenal
venous blood.
Adrenaline and noradrenaline are present in adrenal venous blood in high
concentrations with relatively little contamination. Thus, a simple
extraction procedure is sought which will yield high and consistent
recoveries. The sensitivity of the assay is not a major concern as the
concentration of catecholamine is high in adrenal venous blood.
However, in some experiments, especially denervated adrenal gland
experiments, the catecholamine levels are reduced and therefore, whilst
not a major concern, a good sensitivity is desirable.
It is important for the assay to differentiate adequately between
adrenaline and noradrenaline as xselective release' of catecholamines is
investigated.
Finally, as large numbers of samples are taken during each experiment
(up to 35), a high throughput assay is sought; preferably with large
batch handling as comparison of samples within a batch is often more
reliable than between batches.
- 48 -
Selection of technique
Physico-chemical techniques for the assay of adrenaline and
noradrenaline are based on the observation that adrenaline and
noradrenaline, and particularly their oxidation products, fluoresce.
Vulpian initially described the property of the adrenal gland to form
lightly coloured compounds and Loew (1918) observed that adrenaline, in
strong alkali, produces a yellow-green fluorescence.
Later, in 1930, Paget showed this fluorescence was specific for
adrenaline. Gaddum and Schild (1934) showed the reaction required the
presence of oxygen, and noradrenaline, which also produced fluorescence,
gave a much weaker reaction than adrenaline. Gaddum and Schild (\93q.)
attempted to use this reaction for assay purposes but were largely
unsuccessful owing to the transient nature of the fluorescence. The
breakthrough in the fluorimetric assay of adrenaline and noradrenaline
came in 1948 when Ehrlen stabilised the adrenaline fluorophor by adding
ascorbic acid. Based on this principle, Lund (1950) developed the
method and adapted it to produce the first ^luorimetric estimation of
adrenaline and noradrenaline in blood.
The reaction which occurs involves the oxidation of adrenaline and
noradrenaline to the cyclised adrenochrome and noradrenochrome
respectively. (Richter (1937) and Richter and Blaschko (1937)). The
coloured xchrome' derivatives are then isomerically transformed by the
addition of alkali to form xlutines'; the term first used by Lund
(1949). It was the work of Ehrlen (1948), Lund (1949), Fischer (1949)
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and Harley-Mason (1948, 1950) which finally identified the fluorescent
derivative of adrenaline as l-methyl-3,5,6-trihydroxyindole




The differential assay for adrenaline and noradrenaline used by Lund
(1950) was based upon the pH controlled differences in the oxidation
rates of these amines. This requires splitting the sample and oxidising
with manganese dioxide at pH 3.0 and 6.5 for the oxidation of adrenaline
and noradrenaline respectively. - The sensitivity of this method was
poor. A major improvement came in 1957 when Price and Price
differentiated between the lutines of adrenaline and noradrenaline by
using light at two wavelengths rather than oxidation at two different pH
(1957)
levels. Furthermore, Price and Price"used potassium ferricyanide as the
oxidising agent and reacidified the reaction products from the alkaline
reaction to pH 5.0. This increased the fluorescence intensity and
produced stable fluorophors. (see xNotes on assay')
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Since 1957 the number of variations of the THI technique has mushroomed
and are reviewed in detail by Udenfriend (1962), HHggendal (1966) and
Callingham (1967). The major difference between the various techniques
lies in the choice of oxidising agent and stabilizing reagent used.
e.g.
Oxidising agents
a) Manganese dioxide e.g. Lund (1950), Cohen and Goldberg (1957),
Pekkarinen (1954), Crawford and Law (1958).
b) Iodine e.g. Crout (1961), Laverty and Taylor (1967), Sourkes and
Drujan (1957).
c) Potassium ferricyanide e.g. Price and Price (1957), Bertler et al
(1958), Vendsalu (1960), Anton and Sayre (1962), HMggendal (1963),
Valori et al (1970), Euler and Lishajko (1959).
Stabilizing reagents
(1950) (|957) 0 957)
a) Ascorbic acid e.g. Luncf1, Price and Price*, Cohen and Goldberg^
(13W) I)
Crout^, Anton and Sayre.
b) Sulphur containing compounds
1. British anti-Lewisite (BAL)/Formaldehyde e.g. Valori et al(l9lO).
2. BAL/Sodium sulphite e.g. HHggendalb2>) .
3. Sodium sulphite e.g. Laverty and Taylor(\9bl) •
4. Cysteine hydrochloride e.g. Klensch (1966).
5. Thioglycolic acid e.g. Merrills (1963).
An alternative method to the THI reaction is the ethylenediamine
condensation reaction. In 1949 Natelson, Lugovoy and Pincus found that
catecholamines formed strongly fluorescent condensation products with
ethylenediamine. Weil-Malherbe and Bone (1952) applied this method to
plasma extracts, purified by alumina adsorption, and obtained stable
fluorescent products. By measuring the fluorescence at two wavelengths,
with the use of differential secondary filters, the concentration of
adrenaline and noradrenaline was determined. Several modifications of
this method have been tried; (see Weil-Malherbe, (1959) and Manger,
Wakim and Bollman, (1959)) however, the ethylenediamine condensation
reaction appears to be less specific than the THI reaction. (Holzbauer
and Vogt, (1954), Euler and Floding, (1955), Euler, (1956), Valk and
Price, (1956) and Cohen and Goldenberg, (1957)).
The reaction I have used is the THI reaction. The actual method
employed has its origins in Bertler, Carlsson and Rosengren (1958) with
modifications by HMggendel (1963) and Valori, Brunori, Renzini and Corea
(1970). I have selected from these various techniques and modified them
to suit my own purpose (for details see ''Notes on assay').
Selection of Extraction technique
Before the THI reaction is applied the sample must first be purified.
Three extraction techniques for catecholamines are commonly used,
solvent extraction, adsorption onto alumina and cation exchange
chromatography.
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The first, solvent extraction, (introduced by Weil-Malherbe and Bone
(1954)), is usually applied to biological tissues rather than fluids.
However, solvent extraction without further purification is seldom
adequate for the fluorimetric estimation of catecholamines. (e.g. Chang
(1964)). Therefore, solvent extraction may be deemed redundant.
Of the other two techniques, cation exchange chromatography is by far
the simplest to use and is the technique I have used here. I have used
a weak carboxylic acid resin, Amberlite CG50, (BergstrHm and Hansson
(1951), Kirshner and Goodall (1957)) rather than a strong acidic resin
of the sulphonic acid type (e.g. Bertler et al, (1958), HMggendal (1962,
1963)) - see xNotes on assay" for details.
The extraction procedure depends on the positively charged
catecholamines (at neutral pH) being retained by the negatively charged
carboxylic groups on the resin. The catecholamines are eluted from the
resin using boric acid.
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EXPERIMENTAL PROTOCOL FOR CATECHOLAMINE ASSAY
Adrenal venous samples
Collection of sample
Heparinised blood from the left adrenal gland is collected in
cooled, graduated centrifuge tubes. The tubes are stored in ice
until 2, 3 or 4 are collected.
Separation and storage of plasma
The tubes are immediately centrifuged at 3,000r.p.m., 4°C for 5
minutes.
The plasma supernatant and packed red cell volumes are recorded and
the plasma carefully removed using a pasteur pipette.
lmg/ml of sodium metabisulphite is added to the plasma and the
sample frozen at -20°C for up to 2 weeks.
Preparation of plasma for extraction
The plasma is thawed and centrifuged, 3,000r.p.m., room temperature
for 2 minutes to remove precipitated fibrin.
* From here duplicates of each sample are taken *
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To 1ml aliquots plasma is added 3mls of 0.1N phosphate buffer, pH
7.4 and 0.5mls of 3% EDTA. (If 2mls of plasma are not available the
whole sample is used and diluted as above, in the ratio 1:3:05.
The sample is then split to provide duplicates).
Extraction and purification of catecholamines
The samples are loaded onto Amberlite CG50 (mesh size 100-200)
resin columns of 5cm length and 0.25cm diameter.
The column is rinsed using 5mls of distilled water followed by
0.15mls of 2/3M boric acid.
The catecholamines are then eluted with 1ml of 2/3M boric acid and
collected in test tubes designed to fit both the AC60 autoanalyser
and the spectrophotofluorimeter.
The eluted sample has a pH of 6.5 and is stable at room temperature
for longer than 3 hours.
b) Column blanks
A peripheral blood sample is taken via the femoral artery and
substituted for adrenal venous blood in the above protocol.
6 column blanks are processed.
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c) Column standards
Standard solutions of adrenaline and noradrenaline as l^ig/ml in
10 "^M HC1 are prepared.
0.1ml of each standard is added, in duplicate, to A of the column
blanks at the dilute stage, immediately prior to loading onto the
column. The column standards then follow the rest of the protocol.
Following elution the tubes are placed in the moving conveyor belt of a
Unicam AC60 autoanalyser in strict order.
Ahead of the samples are placed duplicate non-column blanks and
standards.
Non-column blanks:- 1ml of 0.1N phosphate buffer, pH6.5
Non-column standard:- 0.9ml of 0.1N phosphate buffer pH6.5 + 0.1ml of
adrenaline or noradrenaline standard solution.
Spectrophotofluorimetric assay
The samples are assayed in batches of up to 15; the limiting factor
being availability of the glass columns, (36 required for 15 samples





3+4 Non-column adrenaline standard.
5+6 Non-column noradrenaline standard.
7+8 Column blank.
9 +10 Column adrenaline standard.
11 +12 Column noradrenaline standard.
13 -> 42 Samples 1 -> 15 in duplicate.
To all tubes at fixed time points the following reagents are added and
mixed:-





Final pH = 5.0
REAGENT
Potassium ferricyanide (0.05%)





At 30 minutes the sample is transferred to the spectrophotofluorimeter
and the fluorescence read. The fluorescence is stable for more than 3
hours.
Excitation spectrum scanned over the range 300-500mp
Emission wavelength 510mja.
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Notes on Catecholamine Assay
(1) Centrifugation of blood samples
It is known that loss of catecholamine occurs rapidly in whole
blood (Mangan and Mason (1958)) but not in plasma (Jones and Blake
(1958)). For this reason samples are kept on ice and are
centrifuged at 4°C within 6 minutes of collection.
(2) Omission of protein precipitation
HHggendal (1963) omitted protein precipitation from his assay and
claimed he could run up to lOmls of plasma through Dowex 50W-X8 ion
exchange resin (length 3.5cm, diameter 0.27cm) without affecting
recovery.
Using Amberlite CG50 (length 5.0cm, diameter 0.25cm) it is not
possible to use vneat' plasma as column running times are in excess
of 1 hour/ml. However, diluting the plasma greatly reduces running
time. Plasma samples of 1ml (diluted to 4.5ml with phosphate
buffer and E.D.T.A.) will run in 10-15 minutes.
(3) Removal of fibrin
The centrifugation to remove fibrin is not essential to the assay
but, if omitted, will result in xgumming-up' of the columns and
very long running times will result.
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(4) Volume of plasma used for extraction
Samples of more than 3mls of plasma are seldom collected. As
duplicates are taken I have chosen a standard volume of 1ml. Using
a constant volume reduces variation and keeps running times
constant.
No reduction in recovery from the columns occurs using up to 4mls
of plasma. However, if 4mls is exceeded recoveries fall. (see
NChoice of resin'). Samples of 1ml lie well within the efficient
range of the columns.
(5) Choice of extraction technique
The two widely used techniques for catecholamine extraction are
cation exchange and adsorption onto alumina. There is little to
choose between the two techniques for recovery and reliability.
However, the cation exchange technique is quick and simple whereas
the preparation of alumina is long and tedious. Also, the
adsorption of catecholamines onto alumina requires an alkaline pH
which may increase the variability in recovery. Hence, cation
exchange has been used.
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Choice of resin
The ideal resin should allow elution of the catecholamines in a
volume of 1ml or less with recoveries in excess of 90%. Blanks
should also be low and consistent.
Two resins, Amberlite CG50, a weak carboxylic acid resin, and
Amberlite CG120, a strong sulphonic acid resin are compared.
Amberlite CG120
Cna)
HHggendal ^demonstrated that catecholamine loss is a function of
column length, i.e. the shorter the column the lower the recovery.
However, on the other hand, the shorter the column the higher the
flow and smaller volumes are required for elution. A suitable
column length of Amberlite CG120 which gives recoveries
consistently above 90% and adequate flow rates is 2cms.
To elute catecholamines from this strong sulphonic acid resin
either a small volume of concentrated acid (1ml of 4N HC1) or a
2/
large volume of a weaker acid (4ml of IN HC1 or 10ml of 3M Boric
acid) must be used. However, if 4N HC1 is used high and variable
blanks result. Therefore, the best alternative is to elute using
4mis of IN HC1.
The catecholamines contained in this 4mls are further diluted when
neutralised to pH6.5 using 5N potassium carbonate. As 1ml is the
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ideal volume for the catecholamine assay less than a quarter of the
sample is used, resulting in a loss of sensitivity.
Amberlite CG50
To obtain recoveries consistently above 90% a minimum column length
of 3cms is required.
Catecholamines are eluted with ease from the weak carboxylic acid
2 /
resin using 1ml of ' 3M Boric acid. The 1ml eluted sample has a pH
of 6.5 and no neutralisation is necessary. Therefore, sensitivity
of the assay is maximum.
However, lower recoveries can result when the ionic content (or
volume) of plasma is increased. To overcome this a 5cm column is
used and the plasma volume fixed at 1ml. (see '"Volume of plasma
used for extraction').
The reduction in flow which results from increasing column length
from 3 to 5cms is small and of no concern.
If large plasma volumes were to be used, such as assay of
peripheral catecholamines, the Amberlite CG120 would be the resin
of choice. However, as plasma samples rarely exceed 3mls and
duplicates are taken, Amberlite CG50 offers a more sensitive assay
which is also simpler as two steps are omitted; neutralisation and
pipetting of 1ml aliquots.
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Therefore, for the assay of adrenal venous catecholamines,
Amberlite CG50 has been used.
Preparation of resin
Fluorescent contaminants are present in the resin but are removed
by careful preparation.
Preparation is by the method of Renzini et al (1970) and is as
follows:
a) Soak lOg Amberlite CG50 (100-200 mesh) overnight in 200mls of
2N HC1.
b) Wash several times with distilled water to remove fines (2
minutes sedimentation time).
c) Stir for 30 minutes in 200mls of 2N NaOH with a glass paddle
stirrer (Magnetic stirring bars are not suitable as they
produce too much grinding).
d) Wash 8-10 times with distilled water.
e) Stir for 30 minutes in 200mls of 2N HC1.
f) Wash 8-10 times with distilled water.
g) Repeat cycle c)-f) three times.
h) Transfer the resin to a glass column (4cm i.d.) and wash with
0.4M disodium phosphate buffer pH6.5 until the pH of the
effluent is 6.5.
i) Store the resin in the same buffer at 2-4°C.
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j) Rinse the resin 3-4 times with distilled water before loading
into columns.
Recycling of the resin between the expanded sodium form and the
contracted hydrogen form expels impurities. Renzini claims the
resin will keep for up to 4 months in buffer at 2=4°C but as I used
large quantities of resin none was kept for longer than 2 months.
(8) Column type
The columns are glass and consist of a 20ml reservoir above a
narrow bore tube (0.25cm i.d.). A quartz wool plug at the end of
the narrow bore tube retains the 5cm column of resin.
The prepared column is rinsed continuously with distilled water
until the sample is ready for loading.
(9) Rinsing
As the resin is weak there is a danger that an excess of ions will
wash catecholamines off the column. The columns are therefore
rinsed using 5mls of distilled, deionised water. This does not




Following the water rinse, 0.15ml of 3M Boric acid is loaded onto
the column. This does not cause release of any catecholamine from
the column but reduces the dead space the 1ml eluant will have to
2/fill before elution begins. Omitting to add the 0.15ml of 3M
Boric acid does not alter recoveries but does affect the pH of the
eluted sample such that a small volume of acid must be added to
reduce the pH to the required 6.5.
(10) Elution
2/
Catecholamines are eluted using 1ml of 3M Boric acid. A volume
of 1ml is used as this is adequate for virtually complete elution
of catecholamines from the columns and is ideal for use in the
2/
tri-hydroxyindole fluorimetric assay. 3M is the concentration
chosen as boric acid is insoluble at room temperature at higher
concentrations.
Trauther and Messer (1952) reported that adrenaline and
noradrenaline form complexes with boric acid which promotes
elution. The complexes are also highly stable at pH 7-8, making
boric acid ideal for storing catecholamines prior to the
fluorimetric assay.
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Formation of borate-noradrenaline complex
HON<^::XN^CHOHCH2NH2
2HoO + H+ O B
"N>
Borate complexes have been used previously in the extraction of
catecholamines and methods are described by Wright (1958), Mattock,




A pH of 6.5 was used as, at this pH, the derivatives of adrenaline
and noradrenaline have about equal fluorescence and variations of
0.5 pH units make little difference to the final fluorescence.
(12) Duplicates
Duplicates of all samples are taken here as they should be in any
assay. This ensures reliability and provides two chances to obtain
results from the assay should any misfortune occur.
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(13) Blanks and standards
a) Blanks
Blanks are essential to quantify and allow for background
fluorescence. Background fluorescence results from either the
reagents themselves or any contaminants which may be present
in the reagents or not removed from the sample during the
purification procedure.
Two types of sample, or column, blanks are commonly used:-
Non-oxidised blanks, where the antioxidant is added before the
oxidant, and faded blanks, where the antioxidant is not added
until complete oxidation of the catecholamines and their
lutines to non-fluorescent derivatives has occurred.
Whilst these are the best blanks available to use for the
assay of circulating catecholamines, they are not ideal, i.e.
the samples and sample blanks are not treated identically and,
as a consequence of this, errors may result in assessing the
xtrue' value of the blank. - As I am assaying catecholamines
released from the adrenal medulla, and not circulating
catecholamines, the true level is calculated thus:-
Catecholamines released = Catecholamines in adrenal venous
sample - Catecholamines in arterial sample. The assay used is
not sensitive enough to measure peripheral catecholamine
levels but a more accurate measure of
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adrenal release may be made by using an arterial sample as the
sample, or column, blank; treating it identically to any
adrenal venous sample. This makes allowance for the
catecholamines present which are not released by the adrenal
medulla and also avoids any possible error which may arise
through treating samples and blanks differently. An
additional advantage in using this type of blank is that all
tubes are processed in the same way, simplifying the assay and
reducing the likelihood of operator error.
A second type of blank, the non-column or reagent blank, is
also used. This is simply phosphate buffer and is used only
in the standardisation of the spectrophotofluorimetric assay
and not for the calculation of sample fluorescence.
Standards
As with blanks, two types of standard are taken. The first,
column or plasma standards, are used for the calculation of
adrenaline and noradrenaline in the adrenal venous samples.
The second, non-column standards, to provide a measure of
recovery from the columns. Adjustment to correct
catecholamine release for recovery may be made but as all
recoveries lay within 95-100% this was never done.
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(14) Timing
Accurate timing is essential for all stages of the fluorimetric
procedure. This was achieved simply and reliably by using an
automated reagent delivery system, the NUnicam AC60 autoanalyser'.
Using the autoanalyser increases batch handling capacity from about
12 to 120. (120 is the number of sample holders in the
autoanalyser). However, batches larger than 42 were never run
owing to a limited number of columns being available.
(15) Potassium ferrycyanide
Potassium ferricyanide and iodine are widely used for the oxidation
of catecholamines. Iodine is slower to oxidise catecholamines and
is reported to be influenced by laboratory lighting conditions
(Callingham (1967)). On the other hand, potassium ferricyanide
yields more fluorescence from adrenaline and noradrenaline than
oxidation with iodine and, at the same time, reduces interference
from dopamine and dopa (at the wavelengths used). (Weil-Malherbe
(1971), Valori et al (1970)). Therefore potassium ferricyanide is
used here.
A solution of potassium ferricyanide is stable for up to one month




HSggendal (1963) was first to use cupric ions during the oxidation
of catecholamines, claiming they catalysed the oxidation process
and increased the stability, reproducibility and intensity of
fluorescence. Valori et al (1970) confirmed the catalytic effect
of cupric ions but mainly in relation to the oxidation of
Ci«5?0)
adrenaline. Valori et al also noted that cupric ions increased the
fluorescent intensity of adrenolutine, even when added after the
reducing agent or alkalinization; indicating that cupric ions act
during both the oxidation reaction and the rearrangement of the
adrenochrome to adrenolutine.
»*
As it is accepted that metal ions (e.g. Cu and Zn) play a part in
the oxidisation of catecholamines and their derivatives I have
added cupric chloride to the sample, prior to oxidation. Rather
than add the cupric chloride and potassium ferricyanide separately
the procedure is simplified by mixing the two reagents and
dispensing them as one solution.
(17) Sodium sulphite/dimercaptopropanol (B.A.L.)
A mixture of BAL and sodium sulphite is used to stop the oxidation
and stabilize the strongly fluorescent trihydroxyindole
derivatives, adrenolutine and noradrenolutine.
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Ascorbic acid was originally used as the reducing agent by Lund
(1949) and by most workers for the following 10 years. However,
since Vendsald (1960) noted that ascorbic acid in alkali gives rise
to fluorescent oxidation products, which produce high and time
dependent blank values, various attempts have been made to replace
ascorbic acid by other reducing agents, all of them containing
sulphur, e.g. BAL/sodium sulphite mixture (HHggendal (1963)),
thioglycolic acid (Merrills (1963)) and cysteine hydrochloride
(Klensch (1966)). The BAL/sodium sulphite mixture gave the most
satisfactory results, maintaining the high lutine fluorescence seen
with ascorbic acid but yielding smaller and more reproducible
blanks.
The solubility of BAL in sodium sulphite is poor and clear
solutions are difficult to obtain. However, if the solution is
vigorously shaken and only used when fresh (not kept for more than
1 hour) problems such as variable blanks and quenching, reported by
Valori et al (1970), do not occur.
(1910^
Valori et alAattempted to overcome the problem by dissovling BAL at
higher concentrations (removing the need for other antioxidants) in
solutions which increase the solubility of BAL in water. - They
describe a technique in which a solution of 10% BAL in 25%
formaldehyde is used. However, this produces poor fluorescence and
is not as satisfactory as using the original BAL/sodium sulphite
mixture.
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(18) Glacial acetic acid
All samples are reacidified to pH 5.0 by the addition of 0.35mls of
glacial acetic acid.
The stability of fluorescence formed from both adrenaline and
noradrenaline in the presence of a sulfhydryl compound is greatly
enhanced by reacidification. Authors using ascorbic acid as the
reducing agent (Chang (1964) and Price and Price (1957)) found
reacidification did not offer any advantage. Laverty and Taylor
(1967), whilst studying the optimal conditions for the development
of fluorescence, found that oxidation products formed from
adrenaline and noradrenaline by iodine could be sufficiently
stabilized with a solution of sodium sulphite alone, if followed by
acidification. Oxidation with ferricyanide yields more
fluorescence from adrenaline and noradrenaline than oxidation with
iodine; but omission of BAL from the sodium sulphite solution
results in losses of intensity and stability of fluorescence.
In our experience reacidification results in a shift of the
fluorescence spectrum which is maximum at pH 5.0. The first peak
for both catecholamines is greatly reduced whilst the second peak
is increased. The adrenaline fluorescence is increased
preferentially with the ratio:- adrenaline peak height:
noradrenaline peak height, changing from about 0.8 to 1.2 (at
emission wavelength 510mp). Acidification thereby increases the
discrimination of the assay and at the same time prevents fading of
the fluorescence.
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The fluorescence is stable for at least 3 hours at room temperature
and is little affected by a pH change of 0.5 units in either
direction.
(19) Reading of fluorescence
23.5 minutes following the addition of glacial acetic acid the
sample is transferred from the autoanalyser to the
spectrophotofluorimeter, the outside of the tube being carefully
wiped to remove any contamination. The emission wavelength is set
to 510mp and the excitation spectrum scanned from 300mp to scatter,
at about 500mji.
The intensity of the fluorescence is displayed on the linear scale
of an Aminco Bowman Photomultiplier Microphotometer and also on a
xServoscribe' flat-bed recorder. The chart drive of the recorder
is synchronised to the scanning motor switch on the
spectrophotofluorimeter; thus, the chart drive only operates when
a scan is in progress. As the chart and wavelength scanning motor
speed are fixed, and never varied, the wavelength at any position
on the fluorescence trace can be found by its distance from the
start of the scan (123 millimetres is equivalent to lOOmp), i.e. -
excitation wavelength = 300 + (distance in millimetres from
start/123 x 100)mp.
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To minimise the error in reading fluorescence intensity the meter
multiplier switch on the photomultiplier, and the sensitivity
switch, on the flat-bad recorder, are adjusted to give the maximum
reading possible. The scales on both the meter multiplier and the
servoscribe sensitivity were checked and found to be true and
linear.
The fluorescence of the standards, adrenaline and noradrenaline,
were superimposed for easy assessment of the degree of
differentiation.
(20) Selection of wavelengths
The fluorimetric assay has to fulfil two requirements,
1. to provide a sensitive assay for the measurement of
catecholamines and
2. to differentiate between adrenaline and noradrenaline.
The discriminative power of the assay can be quantified using the
method of Gaddum (1959), replacing "activity' with fluorescence
intensity; i.e.:-
I.O.D. = F.I, of Adrenaline/F.I. of Noradrenaline (at the higher wavelength)
F.I. of Adrenaline/F.I. of Noradrenaline (at the lower wavelength)
where I.O.D. is index of discrimination and F.I. is fluorescence
intensity.
Examples of excitation scans at emission wavelengths 500, 510 and
520mp are given (Figs. 4, 5 and 6). As the emission wavelength is
increased from 500 to 520mp the index of discrimination increases
but the fluorescence is reduced, (especially fluorescence due to
noradrenaline), thereby decreasing the sensitivity of the assay.
The sensitivity is maximum at 500mp where the fluorescence of
adrenaline and noradrenaline are equivalent. However, a
differential assay at this wavelength is poor and unreliable as the
scatter, which occurs at lower excitation wavelengths, can
interfere; particularly when catecholamine levels are low. An
emission wavelength of 510mp is a compromise between sensitivity
and discrimination and has been used here except in several early
xselective release' experiments where 520m^i was used. In these
experiments catecholamine levels were high in any case and the
ratio, noradrenaline : adrenaline was the major parameter sought.
375 and 450 mji were selected as the best excitation wavelengths to
use in the differential assay of adrenaline and noradrenaline. The
separation of the two fluorescence traces is maximum at these two
points and interference from scatter and the first, almost
non-existent, peak does not occur. Fluorescence intensity is also
significantly greater than the blank value at these wavelengths.
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Figure5.Reducedphotocopyoffluorescencespectra100ngfadrenalinendnora r n i Emissionwavelength510/j
I.O.D.=8.5
Excitationwavelength(mju)
Figure6Red cedphotocopyoffluorescen espectra100ngadr nalindnoradrenalin
Emissionwavelength520/j I.O.D.=12
50045375 Excitationwavelength(m/j)
(21) Calculation of adrenaline and noradrenaline
Assuming the relationship between fluorescence intensity and
concentration is linear and the fluorescence of the two
catecholamines is additive an equation can be written which
describes the fluorescence at any given point on the spectra.
i.e. F = yN + xA,
where F is the fluorescence intensity, N and A are the fluorescnece
intensities per nanogram of noradrenaline and adrenaline
respectively and y and x are the quantities of noradrenaline and
adrenaline in the sample.
If fluorescence readings are taken at two wavelengths, 375 and
450mji, then a pair of simultaneous equations can be written,
i.e. F^ = yN^ + xAj and F2 = y^ + xA£,
where 1 and 2 refer to 375 and 450mp respectively. Solving these
equations yields,
y = F^(A2/A^)-F2 and x = F2~yN2
^1(A2/A1)-N2 A2
As I usually use lOOng standards of adrenaline and noradrenaline y
and x must be multiplied by 100 to give the amounts of
noradrenaline and adrenaline present in the sample.
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A simple program for use with a ^Hewlett Packard' calculator was
written to solve these equations when analysing samples.
The two assumptions on which these equations are based have been
tested by other authors and found valid. I have tested them
myself, using the assay procedure previously described, by assaying
known concentrations of adrenaline and noradrenaline and also
equivalent mixtures of the two catecholamines. The results are
displayed in figure 7.
A linear relationship between fluorescence intensity and
concentration exists and fluorescence is additive. i.e. The
assumptions are valid for this assay. The results shown are taken
at only one wavelength, 375mji, but the same relationship holds true
at any wavelength.
(22) Discrimination of the assay
The assay was tested for its ability to discriminate between
adrenaline and noradrenaline by assaying known mixtures of
standards.
In the examples given the emission wavelength is 510ryi.
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Figure7Calibrationcurv sofadrenalinedno ad enaline,fluorescencr dt375/510yj Concentrationofeachcatecholamine( g/ l)
MIXTURE CALCULATED (Mean + S.E.)






100 ^ Used as standards
4 90 10 90.5 + 0.6 8.1 + 1.2
4 80 20 79.4 + 0.7 17.4 + 1.4
4 70 30 71.2 + 1.1 27.0 + 1.6
4 60 40 60.1 + 0.8 38.3 + 0.6
4 50 50 52.6 + 1.2 49.5 + 1.2
4 40 60 40.9 + 1.0 57.1 ± 1'5
4 30 70 32.1 + 1.0 67.8 + 1.6
4 20 80 18.2 + 1.1 79.0 + 1.1





The experimental preparation used to investigate the reflex and humoral
release of adrenaline and noradrenaline from the adrenal medulla is
illustrated in figure 8.
The preparation is an anaesthetised dog in which both carotid
bifurcations are vascularly isolated and perfused, at constant pressure,
with the dog's own arterial blood. The release of catecholamines is
stimulated by lowering the carotid sinus pressure (barotest) or,
alternatively, by lowering the oxygen tension of the blood perfusing the
carotid bifurcations by infusing the reducing agent sodium dithionite
(chemotest).
The venous effluent from the left adrenal gland is collected and later
assayed for adrenaline and noradrenaline by the trihydroxyindole
spectrophotofluorimetric technique.
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Figure 8 Diagram of perfusion of vascularly isolated carotid bifurcations






























Dogs were anaesthetised with an i.v. injection of either sodium
pentobarbitone (30mg/kg) or chloralose (55mg/kg) and urethane
(550mg/kg). When using chloralose-urethane the dogs were premedicated
half an hour before induction with morphine sulphate (lmg/kg) dissolved
in 0.9% saline and given sub-cutaneously. The premedication allowed the
large volume of chloralose-urethane necessary for anaesthesia to be
injected with ease and the minimum of trauma.
Anaesthesia was maintained by a continuous i.v. infusion of anaesthetic
at a rate adjusted to just supress the paw withdrawal reflex, - about
10% of the induction dose per hour.
Pentobarbitone anaesthesia was used in only five experiments and was
employed solely to obtain results which could be compared to existing
data obtained in this laboratory from cats under pentobarbitone
anaesthesia. The use of pentobarbitone was not continued as I found it
selectively depressed the' chemoreceptor reflex relative to the
baroreceptor reflex release of catecholamines in the dog. Chloralose-
urethane anaesthesia was used in all other experiments as it has little
reflex depressant activity (Heymans and Neil, (1958)) and is commonly
used in the study of cardiovascular reflexes.
- 84 -
Some adrenal depleting activity has been reported for several
anaesthetics, particularly those incorporating morphine and administered
to cats, (Vogt, (1954), Emmelin and StrBmblad, (1952), Outschoorn,
(1952) and Elliot, (1912)). As morphine has a stimulant action in the
cat but not the dog, the morphine premedication was not considered a
problem. In any case, adrenal collections were not started for at least
four hours following premedication by which time any effect of the low
dose of morphine (lmg/kg compared to about 20mg/kg necessary for
depletion in the cat) used would be negligible. Chloralose-urethane per
se is not known to cause adrenal depletion.
Respiration, Acid-Base Balance and Temperature Control
The trachea was cannulated and connected to a Starling NIdeal' pump.
The lungs were ventilated with a metered oxygen-nitrogen mixture, the
mixture adjusted to maintain PaC°2 at 39mmHg and PaC^ above 150mmHg,
measured from arterial blood samples on a Radiometer BMS 3 analyser.
Any base deficit in the arterial plasma was corrected by injecting the
appropriate volume of sodium bicarbonate (1 molar), according to the
Singer-Hastings nomogram (1948).
The respiration rate was fixed at 25 per minute and the stroke volume
adjusted with reference to the arterial blood gas tensions and
particularly the ventilatory efforts of the dog.
Body temperature was held at 37°C by a heating pad and lamp linked to a
rectal thermistor probe.
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Maintenance of Systemic Arterial Blood Pressure
Systemic arterial blood pressure was constantly monitored and maintained
by an i.v. infusion of Dextran, prewarmed to 37°C.
Systemic arterial blood pressure falls as a result of blood loss through
bleeding and sample collection, prostaglandins released by surgical
trauma (for details see under NProstaglandins and adrenal blood flow')
and bladder reflexes resulting from a distended bladder (e.g. Taylor,
(1968)).
To reduce the quantity of Dextran necessary to maintain systemic
arterial blood pressure the bladder was catheterised and drained and in
some experiments indomethacin (5mg/kg) was given prior to abdominal
surgery to prevent any possible prostaglandin release.
Carotid Perfusion
Both common carotid and lingual arteries were surgically exposed and
prepared for cannulation.
The carotid bifurcations were then prepared for vascular isolation by
placing loose ligatures around all branches between the points of
cannulation on the common carotids and the origins of the lingual
arteries. The branches include the superior thyroid, internal carotid,
external carotid, occipital and ascending pharyngeal arteries and
occasionally other variable and non-identified branches.
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The superior thyroid arteries are tied off immediately and the common
carotid arteries cannulated both ways; blood from one common carotid
perfusing both towards the head via a Watson Marlow MHRE pump. The
cannula from the second common carotid artery is connected to a pressure
transducer for the measurement of systemic blood pressure.
Using a Y-shaped catheter with a cannula connected to each fork both
lingual arteries are cannulated towards the heart and the blood returned
to the animal via the right external jugular (see figure 8).
All loose ligatures are then tied, vascularly isolating both carotid
bifurcations.
The lingual arteries are not ligated but cannulated to maintain blood
flow through the system and thus allow changes in the perfusing blood to
affect the carotid bodies quickly. The resistance is adjusted by a
screw clamp placed around the cannula returning blood to the external
jugular.
A pressure transducer connected to the perfusion circuit, measuring
carotid perfusion pressure (CPP), was linked, through a servo-amplifier
to the Watson Marlow perfusion pump. The servo control system (see
figure 9 for circuit diagram) works by negative feedback to control the
speed of the pump, maintaining a constant perfusion pressure which is
set by a xclock' potentiometer. Thus, carotid perfusion pressure may be
- 87 -
Figure9Circ itdiagramforServoControlAmplifieSystem ComparatorIntegrator
varied by simply turning the potentiometer switch which has been
calibrated in millimetres of mercury (mmHg).
To test the vascular isolation the Watson Marlow perfusion pump should
stop when the flow through the lingual arteries is occluded.
In several of the earlier experiments the lingual arteries were not
cannulated but simply left open, to allow an adequate flow of blood
through the carotid bifurcations. In this instance we had assumed that
anastomosis between the lingual artery and the brain was negligible.
This assumption was questioned, so, to remove any possibility of carotid
blood reaching the brain, the lingual arteries were cannulated and the




Baroreceptor tests are a lowering of the carotid sinus pressure,
produced by lowering the setting on the clock potentiometer by
40mmHg for 60 seconds. This reduces stimulation of the
baroreceptors which initiates the baroreceptor reflex.
A high arterial PaO^ is maintained throughout such that
chemoreceptor stimulation in response to the fall in carotid
perfusion pressure is minimal.
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Chemoreceptor tests
Chemoreceptor tests are a lowering of the PaC^ of the blood
perfusing the carotid bifurcations, at constant pressure, produced
by infusing into it a 1 molar solution of sodium dithionite,
(Critchley and Ungar, (1975)). By altering the rate of infusion
graded hypoxic stimuli can be given down to a PaC^ of zero.
Frequent blood gas samples are taken to monitor the degree of
hypoxia, hypercapnia and acidaemia achieved during each test.
Systemic arterial blood gas tension does not alter when sodium
dithionite is infused into the carotid circuit.
Two types of chemoreceptor test are performed
1. Short duration (CR), where sodium dithionite is infused for
only 90 seconds and the PaO^ reduced to about 25—30mmHg, and
2. Long duration (LCR), where sodium dithionite is infused for up
to 20 minutes and the PaO^ is only reduced to about 45mmHg.
Both vagosympathetic trunks are cut in the neck to abolish any
secondary reflexes from thoracic receptors.
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Examples of the effects of baroreceptor and chemoreceptor tests on
carotid perfusion pressure and systemic blood pressure are shown in
figure 10.
Collection of Adrenal Venous Blood Samples
In the dog the venous effluent from the adrenal gland drains into the
adreno-lumbar vein which then runs only a short distance until it fuses
with either the inferior vena cava or the renal vein.
It is impractical to cannulate the short length of vein between the
adrenal gland and the inferior vena cava, therefore, the adreno-lumbar
vein is cannulated retrogradely to enable collection of adrenal venous
blood.
The adreno-lumbar vein is cleaned and prepared for cannulation a short
distance from the adrenal gland. All tributaries between the gland and
the point of cannulation are tied off. A loose ligature is placed
around the adrenal vein between the adrenal gland and the inferior vena
cava.
Cannulation of the adreno-lumbar vein is the final step in the
setting-up procedure and is not performed until after heparinisation and
the completion of the carotid perfusion circuit.
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Soft, flexible polythene tubing, with as wide a bore as possible, is
used to cannulate the adreno-lumbar vein. Once the tubing is tied in
position the adrenal vein distal to the adrenal gland is ligated.
Adrenal venous blood then flows retrogradely via the cannula and is
either collected in cooled graduated centrifuge tubes or collected in a
reservoir from which blood is returned to the animal at a constant
infusion rate via the left femoral vein. This minimises blood loss.
Adrenal venous blood samples were usually collected over a 2 minute
period; but if adrenal blood flow was either very high or very low the
collection time was adjusted to provide a sample volume of between 2 and
10mls.
In all experiments adrenal venous blood has been collected from the left
adrenal gland. The right adrenal gland lies more superior than the left
and is virtually inaccessible for cannulation.
Denervation of the left adrenal gland
The left splanchnic nerve was identified and cut about 3cms from the
adrenal gland. The retroperitoneal connective tissue was dissected in
an arc around the gland to interrupt additional sympathetic fibres,
particularly around the arteries supplying the gland. The abolition of
the adrenal response to baroreceptor tests, while the pressor response
remained, was taken as evidence of complete denervation.
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This technique of surgically denervating the adrenal gland is traumatic
and produces bleeding owing to the high vascularity of the area. In an
attempt to reduce the trauma two dogs were treated with lignocaine
injections around the adrenal gland and distinct nerve fibres and blood
vessels were crushed between the tips of non-serrated artery forceps.
This produced a temporary but totally complete block of catecholamine
release from the adrenal gland.
This technique was abandoned as lignocaine appears to penetrate the
adrenal gland and act directly on it to prevent even basal release of
catecholamines.





2. Cannulate hind limb vein for anaesthetic infusion.
3. Prepare carotid bifurcations for vascular isolation and perfusion.
4. Cut vagi in the neck.
5. Administer indomethacin (5mg/kg) - if to be given.
6. Open abdomen (Laparotomy).
7. Put animal on respirator.
8. Prepare left adreno-lumbar vein for cannulation.
9. Allow 30 minutes for haemostasis.
10. Administer intravenous heparin (500 i.u./kg).
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11. Set up carotid perfusion and isolate bifurcations.
12. Check blood gases and adjust acid-base balance.
13. Cannulate adreno-lumbar vein and commence adrenal venous
collection.
Experimental Protocol
a) Reflex and Selective Release Experiments (Dogs 1-17, and 34)
A detailed protocol for each experiment is contained in Appendix 2,
vTables of Results from Whole Animal Experiments'.
An outline of the general protocol used for all reflex and
selective release experiments is presented here:-
TIME ACTION
(in minutes)
0 Start control sample collection.
2 Stop control sample collection.
Barotest on (Lower CPP by 40mmHg).
~2.5 Start barotest sample collection (see note 1).
3 Barotest off.
~4.5 Stop barotest sample collection.
9 Start control sample collection.
11 Stop control sample collection.
Chemotest on (Infuse sodium dithionite).
~11.5 Start chemotest sample collection (see note 2).
12.5 Chemotest off.
"13.5 Stop chemotest sample collection.
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The cycle of baroreceptor and chemoreceptor tests is repeated at
about 20 minute intervals. The drugs, hexamethonium bromide and
hyoscine methyl bromide, are normally administered after every two
cycles.
Samples of blood perfusing the carotid bifurcations are taken
during control collections and during periods of chemoreceptor
stimulation (chemotest) for blood-gas analysis and pH
determination.
Note 1 Barotest sample collections are started approximately half
a minute after the start of reflex stimulation in order to
allow for the dead space of the collecting system. The
time delay is calculated for each collection from knowing
the dead space (mis) and dividing it by the adrenal blood
flow (mls/min), assumed to be the same as the preceeding
control period.
The sample is collected for 2 minutes.
Note 2 During chemotests allowance is made for the dead space in
the collecting system as described in note 1. However, as
there is also a delay between starting the sodium
dithionite infusion and initiation of the chemoreceptor
reflex, the dead space allowance is made from the time of
the first forced inspiratory movement of the dog, which is
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assumed to coincide with stimulation of the
chemoreceptors. The chemotest sample is then collected
for two minutes.
Occasionally a second chemotest collection is taken immediately
following the first, (CR'). This was taken to ensure that the peak
release of catecholamines was not being missed.
b) Neural and Endocrine Mechanisms of Catecholamine Release (Dogs
18-33)
A detailed protocol for each experiment is contained in Appendix 2,
NTables of Results from Whole Animal Experiments'.
This study is comprised of 5 groups of experiments. Briefly, they
are:-
1. Effects of Exogenous ACTH.
(Dog nos. 18, 19 and 21-26).
Synacthen, 25 or 250/ug, is infused intravenously. Adrenal
venous collections are taken before, during and at timed
intervals after synacthen infusion.
2. Effects of Long Duration Chemotests (LCR).
(Dog nos. 18, 19, 22, 23, 26, 32 and 33).
Adrenal venous collections are taken before, during and at
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timed intervals after chemotests of either 10 or 20 minutes
duration. (see vStimulation of Reflexes').
3. Effects of LCR in dogs with denervated left adrenal glands.
(Dog nos. 27-31).
Protocol as 2.
4. Effects of LCR in dogs treated with cycloheximide (50mg/kg).
(Dog no. 32).
Protocol as 2.
5. Effects of LCR in dogs with denervated left adrenal glands and
treated with cycloheximide (50mg/kg).
(Dog no. 31).
Protocol as 2.
Samples of blood are taken frequently from the carotid circuit to
monitor the degree of hypoxia during long chemotests. A PaO^ of
45mmHg was aimed for during long chemotests.
All adrenal sample collections were taken over two minutes.
c) Prostaglandins and Adrenal Blood Flow
Most of the information relating prostaglandins and adrenal blood
flow is obtained by comparing two groups of dogs, those given
indomethacin and those not.
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However, one experiment was performed in which the adrenal venous
blood was assayed for PGI^ or, more accurately the metabolite of
PGI2, PG-6-OXO-F^ .
The protocol is similar to that used for NReflex and Selective
Release Experiments' except that only barotests were performed and
indomethacin was the major drug administered rather than
hexamethonium bromide or hyoscine methyl bromide.
For a detailed protocol see Dog no. 20, Appendix 2.
The following parameters were recorded in all experiments and are
presented in Appendix 2:
Arterial blood gas tensions and pH, systemic blood pressure,
carotid sinus pressure, adrenal blood flow and catecholamine
release as adrenaline and noradrenaline. In addition, time from
the start of the experiment and the dog's sex and weight are
recorded.
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Isolated Adrenal Gland Perfusion Experiments
Introduction
There is conflicting evidence over the effects of indomethacin and
prostaglandins on adrenal catecholamine secretion; the controversies
probably resulting from species differences and diverse investigative
methods.
From the results presented herein for whole animal experiments,
(Appendix 2), indomethacin appears to inhibit catecholamine secretion
both at rest and during baroreceptor tests. As systemic blood pressure
and adrenal blood flow are altered by indomethacin it is impossible to
say with certainty that the reduction in catecholamine secretion is a
direct effect of indomethacin and not simply a reflex response to
increased blood flow and systemic blood pressure.
To investigate the effects of indomethacin and prostaglandins on
catecholamine secretion by the adrenal medulla, without interference
from changes in pressure and flow, indomethacin and prostaglandins were
administered to isolated perfused canine adrenal glands.
Source of Glands
Adrenal glands were removed from dogs immediately after death. The
donors were all dogs which had been used by the Department of Medicine,
University of Edinburgh, for the investigation of myocardial damage
- 100 -
following coronary occlusion and had not received any adrenal
stimulants. Unfortunately glands could not be removed prior to death as
removal of the heart marked the end point of the experiment. However,
if the glands are rapidly removed and immediately flushed with
heparinised Locke's solution, the formation of blood clots is prevented
and the resistance to perfusion minimised - If clots have formed the
gland swells and ruptures when flushed.
Removal of Glands
The adrenal glands are cannulated in situ in a retrograde fashion via
the adrenolumbar vein, using a short length of polythene tubing with a
tightly fitting luer needle, with the point removed, fixed in one end.
The adrenal gland is dissected free from the retroperitoneal tissue
surrounding it and the adrenal vein cut beyond the ligature. The gland
is removed attached to the cannula and is immediately flushed with
heparinised Locke's solution. The- gland is stored in Locke's solution
until used some 30 minutes later.
Perfusion
The adrenal glands are perfused with phosphate buffered Locke's solution
(NaCl 154mM, Glucose lOmM, KC1 5.6mM, Na2HP04 2.15mM, NaH2P04.2H20
0„85mM, CaCl2.6H20 2.2mM) at a constant flow of 2mls/minute, delivered
by a Watson Marlow MHRE pump. The Locke's solution is continuously
oxygenated and maintained at 37°C by a heated water bath and passage
through a heated coil. A pump circulates water from the heated bath to
the coil and also to a "Langendorff' jacket which surrounds the gland.
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The gland is suspended in a small glass funnel and effluent from the
gland drips directly from the funnel into collecting tubes held in the
conveyor belt of the Unicam AC60 Autoanalyser. The belt of the
autoanalyser moves every 30 seconds and thus 1ml samples of adrenal
effluent are collected.
Drug Infusions
To ensure equilibration the gland was perfused for a minimum of 60 /
minutes before drugs were administered.
All drugs were infused for 2.5 minutes and samples collected before,








































The test collections do not coincide with drug infusion times as the
dead space is 4mls and 2 minutes are required for the drug containing
perfusate to reach the adrenal gland.
All drugs were made up fresh for each test in Locke's solution,
oxygenated and heated to 37°C in a water bath prior to and during each
infusion. Stock prostaglandin was dissolved in ethanol but was
diluted many-fold in Locke's solution to give the desired concentrations
for use here - A blank of ethanol in Locke's solution produced no change
in catecholamine release from an isolated adrenal gland.
Drug solutions and Locke's perfusate were pumped simultaneously at
2mls/minute by one double carriage Watson Marlow pump, one solution
directed to the adrenal gland and the other recycled. This ensures no
change in flow occurs when the perfusate is changed from Locke's
solution to Locke's containing drug and vice versa. The changeover of
perfusate is made rapidly and smoothly by a single level action which
operates a series of 3-way ta.ps interconnected by a system of short
tubes (see figure 11). This mechanism ensures that no interruption in
flow occurs during changeover. The drug solution remaining in the
system at the end of a test period is completely washed out with Locke's
solution without interfering with the perfusion of the adrenal gland.
In all experiments control collections were taken before and after
changeover to confirm that the changeover procedure itself did not
produce any release of catecholamine from the adrenal gland.
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At least 30 minutes were allowed between drug infusions for catecholamine
secretion to return to a steady state. This also allowed sufficient
time to complete the spectrophotofluorimetric assay of adrenaline and
noradrenaline in the samples collected before starting another run.
Individual experimental protocols of drug infusions are listed in
Appendix 3, xTables of results from isolated adrenal gland experiments'.
Collection of Samples
The moving track of the Unicam AC60 Autoanalyser was used as a fraction
collector for the adrenal effluent, moving every 30 seconds and thus
collecting samples of 1ml.
The adrenal gland was suspended in its heating jacket and funnel above
-r
the track of the AC60 autoanalyser. A short piece of pojtex tubing
attached to the spout of the funnel" is positioned to just touch the rims
of the collecting tubes passing beneath it. This prevented any loss of
effluent as the tubes moved and, by collecting part drops, ensured the
same volume of effluent was collected in each sample.
A waste pipe and funnel was positioned beneath the collecting point to
catch the adrenal effluent between collections.
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Catecholamine Estimation
As the track of the AC60 Autoanalyser moved, sample tubes passing the
collection point were removed, advanced along the track and replaced in
order behind tubes containing either Locke's solution only (blanks) or
standards of adrenaline and noradrenaline made up in Locke's solution,
1 *6«
Tube No.
1+2 - Reagent blanks, 1ml of Locke's solution.
3+4 - Adrenaline standards, lOOng adrenaline in 1ml of Locke's
solution.
5+6 - Noradrenaline standards, lOOng noradrenaline in 1ml of Locke's
solution.
7 - Adrenal sample control [used as faded blank].
8 - 17 - Adrenal samples —
The tubes are positioned immediately before the first reagent dispensing
station on the autoanalyser; a metal pin being placed alongside the
first tube and one space behind the last tube to switch the dispensing
stations on and off respectively.
The tubes pass the four dispensing points and the reagents for the
trihydroxyindole spectrophotofluorimetric assay are added.
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The trihydroxyindole method used here is identical to the method used
for the assay of adrenaline and noradrenaline in adrenal venous samples
collected from whole animals and a full account of the method giving
times, reagent volumes, reading of fluorescence, etc. is already
presented, see Experimental Protocol for Catecholamine Assay -
Spectrophotofluorimetric Assay'.
Blanks
Reagent blanks of 1ml of Locke's solution were used in determining the
fluorescence produced by the adrenaline and noradrenaline standards.
A faded blank, in which the BAL/sodium sulphite mixture was not added
until 15 minutes after the other reagents, was used in the calculation
of catecholamines contained in adrenal samples. A faded blank was used
rather than the reagent blank to correct for any fluorescent
contaminants released from the adrenal gland. However, the difference
between the blanks was negligible indicating very little contamination.
Standards
Tubes containing 1ml of Locke's solution were prepared and incorporated
into the previously described sequence. Just before the oxidising
reagent is added 20}il of either adrenaline or noradrenaline (5;ig/ml) is
added and the solution mixed.
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Stock solutions of adrenaline and noradrenaline (5jig/ml) are made up
using 10~3M HC1.
Calculation of Adrenaline and Noradrenaline
The calculation of adrenaline and noradrenaline in the samples is
carried out using the method previously described. (Notes on
Catecholamine Assay - Calculation of Adrenaline and Noradrenaline). The
peak release occurring during drug perfusion is recorded and expressed
as ng/minute.
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Comments on the Isolated Adrenal Gland Perfusion System
Perfusion of the adrenal glands by the method I have described is an
accepted and established technique. However, the technique is hardly
xphysiological' as the adrenal gland is perfused retrogradely and with
Locke's solution, not blood.
To overcome these two problems the adrenal gland must be perfused in
situ, via the aorta, with the animal's own blood - This technique is
expensive, requiring the use of a whole animal and, as our resources
were limited, we did not attempt it.
An alternative technique is reported, (Nahus, (1970)), which describes
the retrograde perfusion of isolated adrenal glands with dilute
homologous blood. This technique is undoubtedly more physiological but
does require sacrificing animals for blood and, in addition, would
necessitate the inclusion of an — extraction procedure prior to the
spectrophotofluorimetric assay. This would markedly reduce the
throughput of the assay to only two drug infusions per gland.
Therefore, whilst aware of the limitations of the artificial perfusion
technique described, it has been used here to clarify and provide




A. Selective Release of Adrenaline and Noradrenaline
from the canine adrenal gland
Results
We have studied the release of adrenaline and noradrenaline evoked by
the baroreceptor and chemoreceptor reflex from the canine adrenal
medulla, under a variety of different conditions. These include
differing anaesthesia, pentobarbitone or chloralose-urethane; the
presence or absence of the nicotinic and muscarinic antagonists,
hexamethonium bromide and (-)hyoscine methyl bromide, the prostaglandin
synthetase inhibitor indomethacin, and also cycloheximide, an inhibitor
of the release of corticosteroids in response to adrenocorticotrophic
hormone. In addition, catecholamine release has been investigated from
the adrenal medulla of dogs with denervated adrenal glands.
The results are summarised in table 1, which shows the percentage of
noradrenaline released under all circumstances.
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TABLE 1
















CONTROL 17 — 3 39 — 7
(n=18) (n=6)
BAROTEST 20 — 3 37 - 6
(n=9) (n=3)




CONTROL 23-2 34 - 13
(n=41) (n=4)
BAROTEST 25 - 3 25 - 5
(n=23) (n-2)_
CHEMOTEST 21 - 5 16 ± 7
(n=7) (ti=2)
LONG 24 - 5 —
CHEMOTEST (n=5)































































No significant differences in the ratio of noradrenaline:adrenaline were
detected during either control periods, stimulation of baroreceptor or
chemoreceptor reflexes or the infusion of Synacthen (ACTH). In
addition, the ratio of noradrenaline:adrenaline is independent of the
anaesthetic used, an intact nerve supply and the presence of the drugs
cycloheximide, indomethacin and (-)hyoscine methyl bromide.
The only evidence of selective release occurring vin vivo' is a small
but consistent increase in the resting secretion of noradrenaline
following treatment with the nicotinic antagonist hexamethonium bromide.
No evidence for selective release of either noradrenaline or adrenaline
was found on investigating catecholamine release from the isolated
canine adrenal gland; nicotine or prostaglandin E^ being used to evoke
release in the presence or absence of hexamethonium bromide or
indomethacin. Two glands, numbers 2 and 3, appeared to selectively
release noradrenaline when stimulated with nicotine. However, this was
not supported in other glands where nicotine either did not alter the
noradrenaline:adrenaline ratio or even reduced it.
The overall mean percentage of noradrenaline released " in vivo' is
24 + 1 (n = 313, S.D. = 18). If the results in the presence of
hexamethonium bromide are discounted then the mean percentage falls only
slightly, and non-significantly, to 23%.
The mean percentage noradrenaline release "in. vitro' agrees closely with
this and is 22 + 1 (n = 116, S.D. = 15).
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Discussion
Many authors have argued for and against the independent control of the
release of adrenaline and noradrenaline. If one considers only work
where catecholamines are estimated in adrenal venous blood, and not
peripheral blood, then studies on the cat provide the bulk of evidence
in support of independent control (von Euler and Folkow (1953), Folkow
and von Euler (1954), Dtlner (1953)) whereas studies in the dog, in the
main, do not support independent control. (Malmejac (1964), Critchley
(1976)).
To investigate a possible species difference Critchley and Ungar
(Critchley (1976)) studied the release of adrenaline and noradrenaline
from the adrenal medulla of both cats and dogs using similar techniques
of stimulation, collection and assay. As evidence existed in cats
suggesting that stimulation of the baroreceptor reflex preferentially
released noradrenaline and stimulation of the chemoreceptor reflex
preferentially released adrenaline, (Anichkov jet jal_ (I960)), Critchley
and Ungar used these two stimuli to test for independent control of
adrenaline and noradrenaline release. Their results clearly
demonstrated independent control of release in the cat, supporting the
conclusions of Anichkov et_ al(i<)bo).The ratio noradrenaline:adrenaline
rising from 1:1 at rest to 3:1 in the increment over control during
baroreceptor tests and falling from 1:1 to 1:6 during chemoreceptor
tests. In dogs the ratio remained fixed at 1:4 both at rest and during
reflex stimulation, in agreement with
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Malmejac (1964), De Schaepdryver (1959) and Wurtman, Casper, Pohorecky
and Bartler (1968) who also failed to find any evidence for selective
release from the canine adrenal medulla in response to physiological
stimulation.
Although Crithley and Ungar employed similar techniques of reflex
stimulation, adrenal venous collection and catecholamine assay for
studies on both dogs and cats they did not use the same method of
anaesthesia. Cats were anaesthetised with pentobarbitone and dogs with
a mixture of chloralose and urethane. As it is well established that
anaesthetics can effect catecholamine release from the adrenal medulla,
(see ^Methods, Whole animal experiments and DeSchaepdryver (1959)), Dr.
Ungar and I repeated the study in dogs under both chloralose-urethane
and pentobarbitone anaesthesia. The results, as summarised in table 1,
clearly show no evidence for independent control of adrenaline and
noradrenaline release by the baroreceptor or chemoreceptor reflex under
either chloralose-urethane or -pentobarbitone anaesthesia. The
percentage of noradrenaline released remains fixed at about 20-25% which
is in agreement with figures quoted by other workers. Therefore, the
difference demonstrated between cats and dogs is not due to differences
in anaesthesia. The collected results are published (Critchley, Ellis
and Ungar (1980)) and the paper is attached in the back of this thesis.
Through studying the reflex release of catecholamines from dogs under
pentobarbitone anaesthesia we were surprised to find the adreno-
medullary response to the chemoreceptor reflex was markedly inhibited,
(in all but one dog), relative to the baroreceptor reflex in spite of
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strong respiratory and vascular responses. The opposite, depression of
the baroreceptor response relative to the chemoreceptor response, has
been reported for cats under chloralose anaesthesia (Neil, Redwood and
Schweitzer, (1949)). This reinforces the need for careful consideration
before selecting an anaesthetic especially for use in reflex
experiments. It is for this reason that we have used
chloralose-urethane anaesthesia in the dog for all adrenomedullary
reflex experiments, apart from the one particular study where
pentobarbitone was used for comparative purposes.
Although in agreement that the baroreceptor and chemoreceptor reflexes
do not selectively release adrenaline or noradrenaline I have presented
data which suggests the nicotinic antagonist, hexamethonium bromide,
increases the percentage of noradrenaline in the resting release. More
accurately, as hexamethonium reduces the basal secretion of
catecholamines from the adrenal medulla, it selectively reduces the
release of adrenaline. As the canine adrenal medulla contains both
muscarinic and nicotinic receptors which mediate catecholamine release,
(Kayaalp and Ttlrker (1969)) this would suggest that stimulation of the
muscarinic receptors would selectively increase noradrenaline release.
Similar findings have been reported by others. Kayaalp and Mclsaac
(1968) have reported a selective increase in noradrenaline release with
methacholine (10-20pg/kg), a muscarinic receptor stimulant, as compared
to dimethylphenylpiperazinium iodide, (3-5jig.kg), a nicotinic receptor
(\9b&)
stimulant. In addition, Kayaalp and Mclsaac* also found acetylcholine
selectively released noradrenaline in the presence of the nicotinic
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antagonist mecamylamine. However, acetylcholine was also reported to
increase noradrenaline release in the presence of the muscarinic
antagonist atropine. De Schaepdryver (1959), who reported no selective
release following carotid occlusion, also measured catecholamine release
stimulated by acetylcholine in the presence of atropine. He detected a
substantial reduction in the percentage of noradrenaline released
following pretreatment with atropine (40% before atropine and 20%
after). De Schaepdryver also claimed low doses of nicotine (O.lmg/kg)
reduced the percentage of noradrenaline released. However, this change
was small, 37 to 29 percent, and as the dose of nicotine was increased
the percentage of noradrenaline released was also increased e.g.
1.5mg/kg nicotine increased the percentage of noradrenaline from 32 to
38 percent.
Apart from experiments involving nicotinic and muscarinic agonists and
antagonists, selective release has been reported which is dependent on
the frequency of stimulation of—the splanchnic nerve. Increasing
frequency caused increased release of noradrenaline. (Rapela and Covian
(1954), Klepping (1956), Rapela (1956) and Malmejac jet al (1957)).
Although this evidence indicates independent control of release of
adrenaline and noradrenaline in the dog, the noradrenaline released
never exceeds the adrenaline even when selective release of
noradrenaline is occurring. Thus, the majority of the evidence
supporting independent release in the dog, is based on small, and
frequently non-significant alterations in the ratio of noradrenaline:
adrenaline. The evidence for independent control of release of
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adrenaline and noradrenaline from the cat, not only by the baroreceptor
and chemoreceptor reflex (as previously discussed) but also by nicotinic
and muscarinic stimulation (Douglas and Poisner (1965), Critchley
(1976)) is much more convincing. On comparing cat with dog it would be
easy to dismiss any variation in the noradrenaline:adrenaline ratio in
the dog as small and probably insignificant. However, the resting
release of noradrenaline:adrenaline in the dog is about 1:4 compared to
1:1 in the cat, such that any small change in the percentage of
noradrenaline released in the dog may be of more physiological
significance than it would be in the cat. If independent control of
adrenaline and noradrenaline does occur in the dog then a study
comprising large numbers under very controlled conditions may be
necessary to confirm it. Also, if as suggested by the authors cited
here, the release of noradrenaline from the canine adrenal medulla is
under muscarinic control, then a different and opposite functional role
of muscarinic and nicotinic receptors of the cat and the dog will have
been identified. —
- 118 -
B. Effects of Cholinergic Antagonists on the
Reflex Release of Catecholamines from the
canine adrenal gland
Results
In anaesthetised dogs the release of adrenaline and noradrenaline from
the adrenal medulla was studied following stimulation of the carotid
baroreceptor and chemoreceptor reflexes.
The action, on reflex catecholamine release, of the nicotinic
antagonist, hexamethonium bromide, the muscarinic antagonist (-)hyoscine
methyl bromide and both drugs combined was investigated.
Only dogs which produced matched pairs of baroreceptor and chemoreceptor
tests were used to calculate the results. Any mismatched stimuli were
disregarded (Marked * in tables 2-7).
The abbreviations used in the tables of results (tables 2-7) are:-
CPP = Carotid perfusion pressure.
C. A. = Catecholamine (Adrenaline + noradrenaline).
C6 = Hexamethonium bromide.
-HMB = (-)Hyoscine methyl bromide.
BR = Baroreceptor test.
CR = Chemoreceptor test.
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The action of hexamethonium bromide on the release of
catecholamines from the adrenal medulla
In 7 dogs baroreceptor and chemoreceptor tests were performed
before and between 15 and 80 minutes after the intravenous
administration of the nicotinic antagonist hexamethonium bromide
(lOmg/kg). This dose is several times the minimum effective dose
as 2mg/kg is equally effective in abolishing any pressor response
due to baroreceptor tests. The high dose ensures effective block
for at least 80 minutes and is still selective for nicotinic
receptors.
As the systemic blood pressure falls after hexamethonium
administration the drug was given along with an infusion of dextran
to reduce the fall.
The results are displayed in tables 2 and 3.
Hexamethonium significantly inhibited the adrenal response to both
baroreceptor and chemoreceptor tests. The inhibition was
consistently greater during baroreceptor tests.
The action of (-)hyoscine methyl bromide on the release of
catecholamines from the adrenal medulla
In 4 dogs baroreceptor and chemoreceptor tests were performed
before and between 15 and 70 minutes after the intravenous
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administration of the muscarinic antagonist (-)hyoscine methyl
bromide (lOmg/kg).
The results are displayed in tables 4 and 5.
(-)Hyoscine methyl bromide significantly inhibited the adrenal
response to both baroreceptor and chemoreceptor tests. In two dogs
the chemoreceptor response was more substantially inhibited and in
one dog the baroreceptor response was more inhibited.
c) The combined action of hexamethonium bromide and (-)hyoscine methyl
bromide on the release of catecholamines from the adrenal medulla
In 2 dogs there was no residual response to either baroreceptor or
chemoreceptor tests in the presence of both antagonists (lOmg/kg of
each).
The results are displayed in tables 6 and 7.
The resting output of one dog was approximately zero and was much
reduced in the other.
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Figure 12 Inhibition of reflex catecholamine release by nicotinic and
muscarinic antagonists.
After After After
hexamethonium (—) hyoscine methyl hexamethonium
bromide bromide and (—) hyoscine
The columns represent the percentage inhibition of the mean catecholamine
release from the left adrenal gland in dogs, during baroreceptor and chemo-
receptor tests, by hexamethonium bromide (10 mg/kg), (—) hyoscine methyl
bromide (10 mg/kg) and both antagonists together, in groups of 7, 4 and 2
dogs respectively.
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Figure 12 shows the adrenal response to both baroreceptor and
chemoreceptor reflexes is dependent on both nicotinic and
muscarinic transmission. Nicotinic transmission IS the more
dominant of the two.
The results also suggest a possible difference in the transmission
of the baroreceptor and chemoreceptor reflexes. The baroreceptor
reflex being more dependent on nicotinic transmission and the
chemoreceptor reflex more dependent on muscarinic transmission.
This is discussed.
The ratio of noradrenaline:adrenaline remained constant, about 1:4,
in all samples assayed.
The effect of hexamethonium bromide on sympathetic ganglionic
transmission of vasomotor reflexes from the carotid baroreceptors
and chemoreceptors of the dog —
In one dog, no. 34, no adreno-lumbar vein large enough to cannulate
was present. We were therefore unable to collect and assay adrenal
venous blood.
We took the opportunity to repeat an experiment of the type
described by Henderson and Ungar (1978) which measures vascular
resistance changes in a perfused hind limb following stimulation of
the carotid baroreceptor and chemoreceptor reflexes. The only
difference between our technique and that described by Henderson
- 129 -
C«78)
and Ungar is the anaesthetic used. - The results are discussed with
this point in mind.
Baroreceptor and chemoreceptor tests were matched to give similar
rises in hind limb perfusion pressure. Changes in hind limb
perfusion pressure were then measured during baroreceptor and
chemoreceptor tests before and after hexamethonium bromide
(lOmg/kg), guanethidine (2mg/kg) and phentolamine (lOmg/kg); added
wa.s
in that order. The hexamethonium A still effective when the
phentolamine v/as added.
The results, expressed as percentage inhibition of the rise in hind
limb perfusion pressure, are presented in figure 13.
Hexamethonium bromide almost completely inhibited the rise in hind
limb perfusion pressure during baroreceptor tests but only
inhibited the chemoreceptor response by about 50-60%.
Addition of guanethidine produced total inhibition of any residual
response to the baroreceptor test but did not alter the
chemoreceptor response remaining after blockade by hexamethonium.
Subsequent addition of phentolamine completely abolished any rise
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The results are taken from Dog no. 34.
The columns represent the percentage inhibition of the increase in hind
limb perfusion pressure, which occurs during baroreceptor and chemoreceptor




Feldberg, Minz and Tsuda-imura (1934), found the response of the cat
adrenal medulla to acetylcholine and splanchnic nerve stimulation could
be abolished by a combination of nicotine and atropine but not by either
drug alone. This led to the discovery that drugs acting at muscarinic
receptors in the cat selectively control adrenaline release whilst drugs
acting at the nicotinic receptors in the cat selectively control
noradrenaline release form the adrenal medulla (Douglas and Poisner
(1965), Rubin and Miele (1968) and Critchley (1976)).
The possibility of separate physiological roles for the two types of
receptors in the cat was supported by Anichkov et al (1960) and
Critchley, Ellis and Ungar (1980) who showed that carotid baroreceptor
and chemoreceptor activity selectively regulates adrenal release of
noradrenaline and adrenaline respectively. Critchley et al (1980) also
demonstrated total inhibition of the baroreceptor response by a dose of
hexamethonium bromide which did not alter the chemoreceptor response.
This finding is also supported by the early work of Tenney (1956), who
found that hexamethonium did not inhibit the adrenal catecholamine
release nor the increase in systemic blood pressure in response to
breathing 12-33% carbon dioxide.
This suggests the existence of two separate pathways in the cat, one
nicotinic and one muscarinic, mediating the baroreceptor and
chemoreceptor reflexes, namely,
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Baroreceptor reflex -> Nicotinic ——> Noradrenaline release
and, Chemoreceptor reflex > Muscarinic > Adrenaline release
In the dog baroreceptor and chemoreceptor activity regulate the total
output of catecholamines but not the ratio of noradrenaline:adrenaline.
However both muscarinic and nicotinic receptors, similar to the cat, are
present in the canine adrenal medulla and both regulate catecholamine
release under normal physiological conditions (Kayaalp and TUrker
(1968), (1969), Kayaalp and Mclsaac (1969)). To investigate the
possibility of two distinct pathways, one nicotinic and one muscarinic,
mediating baroreceptor and chemoreceptor reflexes to the canine adrenal
medulla, we studied the reflex release of catecholamines in the presence
of nicotinic and muscarinic antagonists.
In the dog we found that both baroreceptor and chemoreceptor reflexes
are more sensitive to nicotinic blockade and less sensitive to
muscarinic blockade. However, muscarinic blockade still produces a
marked reduction in the catecholamine release in response to both
baroreceptor and chemoreceptor reflex stimulation. The situation in the
dog is therefore not as simple as it is in the cat where a clear
division between baroreceptor and chemoreceptor reflexes is found. For
the dog we must postulate that both nicotinic and muscarinic receptors
are involved in the transmission of the baroreceptor and chemoreceptor
reflex to the adrenal medulla. None-the-less, the results do indicate
some slight selectivity of the baroreceptor and chemoreceptor reflexes
for nicotinic and muscarinic receptors respectively.
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Other work also suggests reflex/receptor selectivity in the dog. In the
one experiment (Dog 34) where we measured changes in hind limb
perfussion pressure, hexamethonium selectively inhibited the
baroreceptor response compared to the chemoreceptor response, even after
administration of guanethidine. This implies that transmission of the
baroreceptor reflex by the sympathetic ganglia and also by the adrenal
medulla is predominantly nicotinic. Henderson and Ungar (1978), who
conducted a full study with this type of experiment using both
hexamethonium bromide and hyoscine methyl bromide, demonstrated that
sympathetic ganglion synaptic transmission during the baroreceptor
reflex is mediated by nicotinic receptor activation and transmission
evoked by chemoreceptor stimulation involves predominently muscarinic
(W«)
receptor activation. Henderson and UngarA report that guanethidine
completely abolishes any change in hind limb perfusion pressure in
response to either the baroreceptor or chemoreceptor reflex; indicating
no involvement of adrenal catecholamines in the hind limb response.
This is odd, as intravenous administration of adrenaline and
noradrenaline at doses equivalent to that released from the adrenal
medulla during reflex stimulation would undoubtedly result in
vasoconstriction. A possible explanation of why we still see a
chemoreceptor response in the hind limb following hexamethonium and
guanethidine, is that the chemoreceptor reflex has a large muscarinic
component, which releases catecholamines from the adrenal medulla of
dogs under chloralose-urethane anaesthesia, but may even inhibit
catecholamine release from dogs under pentobarbitone anaesthesia, as
0178)
used by Henderson and Ungar. (Effects of pentobarbitone anaesthesia on
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the chemoreceptor reflex are reported in this thesis). Whilst this
would explain Henderson and Ungar's lack of response to chemoreceptor
stimulation following guanethidine it would not explain the lack of
response to the baroreceptor reflex. Henderson and Ungar have not
published figures for guanethidine effects and state that close arterial
injection of guanethidine to the hind limb abolishes the response to
chemoreceptor stimulation. The baroreceptor response is not mentioned.
It may therefore be possible that some residual response to stimulation
of the baroreceptor reflex did remain following guanethidine but was at
the time considered to be insignificant. Alternatively in the animals
used, the baroreceptor reflex may not have been strong enough to evoke
catecholamine release sufficient to effect the hind limb response.
Further evidence in support of baroreceptor and chemoreceptor reflexes
being mediated by nicotinic and muscarinic receptors respectively comes
from the work of Shepherd's group (Pelletier (1972), Pelletier and
Shepherd (1972), Webb-Peploe and Shepherd (1968)) and Professor James
Black (personnal communication from Critchley (1976)). Professor Black
has demonstrated that nicotinic agonists selectively constrict arteries
and muscarinic agonists selectively constrict veins in the cat.
Shepherd's group have shown the baroreceptor reflex to selectively
constrict arteries and the chemoreceptor reflex to selectively constrict
veins in the dog hind limb, i.e.
Baroreceptor reflex > nicotine ■> arteries.
Chemoreceptor reflex > muscarinic > veins.
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If two separate pathways common to the cat and the dog do exist, one
mediated by nicotinic receptors and the other by muscarinic receptors,
then how is each pathway selectively triggered?
The simplest explanation of two separate pathways to the chromaffin
cells of the adrenal medulla and to the sympathetic ganglion is two
separate nerves or nerve fibres, one nicotinic and one muscarinic.
Although this is possible there is no anatomical or electrophysiological
evidence to support it. The most likely possibility is for different
firing patterns within one nerve to relay different reflexes and
stimulate different receptors.
The work of Voile's group, (Takeshige and Voile (1962), (1963),
Takeshige et al (1963), DeGroat and Voile (1963), Voile (1963)) on the
response of the sympathetic ganglia of the cat to acetylcholine, has
clearly demonstrated an early excitatory postsynaptic potential (EPSP),
which is susceptible to blockade -by the standard nicotinic ganglionic
blockers, and a late EPSP which is resistant to nicotinic block but is
blocked by small doses of atropine. The late, or slow, EPSP is similar
to that produced by muscarine. (Ambache et _al (1956), Sanghvi and Unna
(1963), Jones and Trendelenburg (1965)). Voile (19b2>) also noted that
prior conditioning of the ganglia with tetanic stimulation enhanced the
firing produced by muscarine and muscarinic agonists; whereas without
prior conditioning large doses of acetylcholine were necessary to
activate the late atropine sensitive asynchronous discharge in
postganglionic fibres.
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From this we can form a hypothesis to explain separate activation of
nicotinic and muscarinic receptors by one neural route. The slow EPSP's
of the muscarinic type would be expected to summate with rapid
non-synchronous firing of the chemoreceptor type, the ganglia or adrenal
medulla being at the same time conditioned by the continuous firing to
produce slow EPSP's, whereas the short, fast, nicotinic EPSP would
summate with synchronous firing of the baroreceptor type. The reflex
induced nerve impulses would thereby dictate the receptor to be
activated.
It is unfortunate that most of the work on catecholamine release in
response to different patterns of nervous impulses has been done in the
calf (Edwards et al (1980), Edwards (1981)a,b) as, although the bovine
adrenal medulla possesses both nicotinic and muscarinic receptors,
(Kayaalp and Neff (1979)) only stimulation of the nicotinic receptors is
reported to release catecholamines. (Wilson and Kirshner (1977)). I
found only one paper claiming muscarinic stimulation of catecholamine
release, (Hawthorne and Mohd. Adnan (1981)), which claimed release by
carbachol in the presence of 2 x 10 tubocurarine. However, in
another paper reporting a similar experiment, tubocurarine at 4 x 10
was reported to completely abolish any catecholamine release stimulated
by carbachol. (Fisher et al (1981)). None-the-less, Edwards has shown
selective release of adrenaline and noradrenaline is possible by simply
altering the pattern of nerve stimulation. I would agree therefore with
his final statement in the discussion from Edwards (1981) b) which
reads,
- 137 -
"This finding obviates the necessity to involve separate efferent
pathways to the separate types of chromaffin cell (Palkama (1962,
1964)), although the existence of separate pathways remains an open
question."
Stimulation of the muscarinic receptor in the bovine adrenal medulla
does not release catecholamines but has been reported to inhibit the
release of catecholamines (Derome et al (1981), Lemaire et al (1980))
and has been suggested to act by increasing cyclic GMP levels. (Lemaire
et al (1981)). However, whilst it is generally accepted that cyclic GMP
is increased in the presence of muscarinic agonists it is not widely
accepted that the increase in cyclic GMP and stimulation of the
muscarinic receptor are synonymous. (Schneider et. al (1979), Yanagihara
et al (1979), El-Fakahany and Richelson (1981)).
Kebabian et al (1975) whilst studying the bovine sympathetic ganglion,
postulated that an increase in the -neural concentration of cyclic GMP in
sympathetic ganglia is involved in the mechanism which generates slow
EPSP's in the postganglionic neurons. Support for this theory comes
from work on the frog, (Weight ejt al. (1974), Nishi and Koketsu (1968))
whilst evidence against it comes from work on the rat, (Frey and Mclsaac
(1981)) and the rabbit. (Dun j|t al (1977), (1978)). In conclusion
there appear to be both quantitative and qualitative differences among
species in the mechanisms which generate cyclic GMP responses.
Whether cyclic GMP is responsible for mediating muscarinic responses in
either the dog or cat sympathetic ganglia or adrenal medulla is not
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known. However, a single neural pathway may exist which mediates both
nicotinic and muscarinic responses and cyclic GMP may be involved in the
muscarinic transmission. In the bovine adrenal medulla the same could
be true where muscarinic stimulation, without releasing catecholamines
per se, may modify the release or even alter the ratio of
noradrenaline:adrenaline released.
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C. The Role of the Pituitary-Adrenocortical Axis in Reflex
Responses of the Adrenal Medulla of the dog
Results
The release of adrenaline and noradrenaline from the adrenal medulla in
response to long duration chemoreceptor tests was studied in 4 groups of
dogs.
The first group consisted of 5 control dogs; the second of 5 dogs with
denervated left adrenal glands; the third of 1 dog pretreated with
cycloheximide (50mg/kg), and the fourth group of one dog also pretreated
with cycloheximide (50mg/kg) but in addition the left adrenal gland was
denervated.
In all dogs the catecholamine release from the left adrenal gland was
measured before and during baroreceptor tests and at timed intervals
before, during and after long chemoreceptor tests. The long
chemoreceptor tests were of 20 minutes duration in the first and second
groups and of 10 minutes duration in the third and fourth groups and
consisted of lowering the PO2 of the carotid perfusate from above
lOOmmHg to about 45mmHg in all dogs.
The abolition of the adrenal response to baroreceptor tests, while the
pressor response remained, was taken as evidence of complete denervation
of the left adrenal glands.
The results of all 4 groups of dogs are presented in figure 14.
- 140 -
























(n = 1 )
2-
10 15 20 25 30 35
Denervated + Cycloheximide (n = 1)
10 15 20 25 30
Figure 14. Responses of dogs to baroreceptor and long chemoreceptor tests. The columns represent the mean output
of catecholamines from the left adrenal gland during control periods (C), baroreceptor tests (B), and at set times from
the start of the long chemoreceptor test (shown in minutes). Catecholamine output preceeding the long chemoreceptor
test given the value of 1. The vertical bars represent the S.E. of the mean. The solid horizontal bars represent the
duration of the long chemoreceptor tests in which the PO2 of the carotid perfusate is reduced from above 100 mmHg
to about 45 mmHg. The panels, from top to bottom, show the mean responses of, J. untreated dogs, 2 dogs with
denervated left adrenal glands, 3 dogs given cycloheximide (50 mg/kg) and 4 dogs with denervated left adrenal glands
also given cycloheximide (50 mg/kg). u\6. V\&.Vc.Vvrx\ r&bre.Se.rxt's "Fhe. Cor\1"i~ol catechol&.ITMC\e. output
irr\mle<ji>a.Ve.\y pre.cte.<i>r»^ ^-VNernore-cepVor Vest.
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Adrenal venous collections were not always taken at the times indicated
in figure 14. When this was the case an estimate of the catecholamine
release was made. This I did by assuming a linear relationship between
catecholamine release and time between any two adjacent adrenal venous
collectons. The release was thus estimated from adrenal venous
collections made either side of the time period indicated.
Chemoreceptor Tests in control dogs (Group 1)
Dog numbers 22, 23, 26, 32 and 33.
In all 5 dogs baroreceptor tests produced marked increases in
catecholamine output.
Long chemoreceptor tests, of 20 minute duration, produced a rapid rise
in catecholamine output which was sustained throughout the stimulus and
remained slightly elevated beyond 20 minutes after the stimulus.
Chemoreceptor Tests in dogs with denervated left adrenal glands (Group
I1
Dog numbers 27, 28, 29, 30 and 31.
Long chemoreceptor tests, of 20 minute duration, produced increases in
catecholamine output which outlasted the stimulus. However, in contrast
to dogs with innervated adrenal glands, no release was observed during
the first 5 minutes of chemoreceptor stimulation or during baroreceptor
tests.
The Effect of Cycloheximide on the response of dogs with innervated
adrenal glands to chemoreceptor tests (Group 3)
Dog number 32.
Cycloheximide, a drug which inhibits the release of corticosteroids in
response to corticotrophin (Garren, Ney and Davis (1965)), did not
affect the immediate release of catecholamines occurring during
chemoreceptor stimulation or baroreceptor tests, but abolished any
catecholamine release occurring beyond 5 minutes of chemoreceptor
stimulation.
The combined effect of Cycloheximide and Denervation on the adrenal
response to chemoreceptor tests (Group 4)
Dog number 31.
Cycloheximide and denervation in combination completely abolished any
increase in catecholamine output during baroreceptor tests and during
the first 5 minutes of chemoreceptor stimulation. The increase in
catecholamine output occurring beyond 5 minutes of chemoreceptor
stimulation was greatly reduced but not abolished. This implies the
cycloheximide block in this dog was incomplete.
- 143 -
The effect of exogenous corticotrophin (Synacthen) on adrenomedullary
catecholamine output
Dog number 18, 19 and 21-26.
In 6 dogs Synacthen was infused intravenously either at 25jig/min for 10
minutes, 25^ig/min for 1 minute or 6.25pig/min for 4 minutes.
At all infusion rates Synacthen produced a large increase in
catecholamine output which was maintained for up to and even beyond 60
minutes. The time to peak catecholamine output varied between dogs,
being almost immediate in some and up to 50 minutes after infusion in
others.
(-)Hyoscine methyl bromide (lOmg/kg) was administered to one dog (Dog
no. 24) between infusions of Synacthen (25jig/min for 1 minute). No
reduction in catecholamine release jto Synacthen infusion was observed.
In two dogs (Dogs no. 25, 26) Synacthen (25pg/min for 1 minute) was
infused following administration of hexamethonium bromide (lOmg/kg) and
(-)hyoscine methyl bromide (lOmg/kg). Hexamethonium and hyoscine
reduced the resting release of catecholamines to zero and Synacthen
infusion produced no increase up to 20 minutes following infusion.
Samples were not taken for long enough to say conclusively that all
response to Synacthen was abolished. However, in all other dogs




We attempted to assay adrenal venous hydrocortisone levels within this
series of experiments. However, our attempts appeared to be
unsuccessful as we could demonstrate no real change in hydrocortisone
levels even during Synacthen infusion, which is used clinically to
test adrenal cortical function. Our methods are presented in Appendix
1 and the results are included in Appendix 2, but no attempt has been
made to interpret them.
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Discussion
In our earlier experiments we investigated the response of the adrenal
medulla to short hypoxic stimuli, localised to the carotid bifurcations,
lasting 90 seconds. We always found the release of catecholamines began
and ended sharply with the beginning and end of the stimulus (allowing
time for hypoxic blood to wash out of the perfusion system) as one would
expect of a reflex response mediated by the autonomic nervous system.
Critchley and Ungar (1974) observed however, that if the stimulus was
prolonged to 20 minutes the release of catecholamines outlasted the
stimulus by at least a further 30 minutes, although both the adrenal
glands and the central nervous system remained perfused with well
oxygenated blood throughout the experiment. A secretory response which
outlasts the stimulus by more than a few minutes is more likely to be
mediated by a humoral mechanism than a neural mechanism. The crucial
test of such a hypothesis is to divide the motor nerves supplying the
effector organ.
We successfully achieved this in 5 dogs and were indeed unable to
abolish the release of catecholamines in response to chemoreceptor
stimulus although the initial, presumably neurally mediated, release was
abolished. It is possible that this response, like tachycardia and
vasodilation, could be a secondary neural or chemical consequence of
increased pulmonary ventilation evoked by carotid body hypoxia (Daly and
Scott (1963)). However, this possibility is excluded in our expeirments
since the lungs were ventilated at a constant rate and the vagi were
cut.
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We took as a working hypothesis the involvement of the pituitary-
adrenocortical axis since we know that carotid chemoreceptor
stimulation, dependent on intact nerves, releases corticotrophin from
the anterior pituitary and thus corticosteroids from the adrenal cortex
of the dog (Anichkov et al (1960), Lau and Marotta (1969), (1970),
Marotta (1972)) and also the rat, (Marks et al (1965)). To test this
hypothesis we performed two types of experiment. Firstly we
investigated the action of cycloheximide, a drug known to inhibit the
release of corticosteroids in response to corticotrophin, (Garren et al
(1965)), on the release of catecholamines evoked by carotid body
hypoxia. The immediate release of catecholamines during both
baroreceptor and chemoreceptor tests was not impaired by cycloheximide.
However, the sustained release in response, to chemoreceptor tests was
abolished by cycloheximide, indicating the involvement of
corticosteroids in mediating the late component of catecholamine release
in response to carotid body hypoxia. Secondly we investigated the
adrenomedullary response to infusion of exogenous corticotrophin, as
Synacthen - a synthetic analogue of corticotrophin. Synacthen produced
large increases in catecholamine output. This was also found by
Critchley and Ungar (1974) who in addition demonstrated inhibition of
the corticotrophin response by cycloheximide. Combining my results from
dogs with denervated adrenal glands and Critchley's (1976) results from
infusing Synacthen we can show a similar time course for the
adrenomedullary response to Synacthen infusion (25^ig over 20 minutes)
and to a 20 minute chemoreceptor test in dogs with denervated adrenal
glands. My own data using Synacthen is not compatible as I rapidly
infused large doses. However, if my results are compared from the end
of the infusion where 25jug of Synacthen was given in both cases, then
the results are similar.
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Finally, Critchley et al (1975) have shown that hydrocortisone releases
catecholamines from the isolated perfused canine adrenal gland, thxS
release not being blocked by cycloheximide (Henderson (1980)).
In summary, the evidence supporting involvement of the pituitary-
adrenocortical axis in reflex responses of the canine adrenal medulla is
as follows
1. The release of catecholamines from the adrenal medulla, in response
to carotid body hypoxia, may outlast the stimulus.
2. Denervation of the adrenal gland abolishes the immediate release of
catecholamines in response to carotid body hypoxia but the
prolonged release remains.
3. The prolonged release of _ catecholamines is abolished by
cycloheximide.
4. Both corticotrophin xin vivo/ and hydrocortisone in the isolated
perfused adrenal gland release adrenomedullary catecholamines.
5. Carotid body hypoxia has been shown to release corticotrophin from
the anterior pituitary.
Few other workers have investigated the effect of adrenocortical
function on the release of catecholamines, although many have
investigated its action on the synthesis of adrenaline. I was only able
to find reports from three groups which I considered relevant to this
discussion.
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Roffi et al (1966) demonstrated that corticotrophin and hydrocortisone
increased adrenaline release from the adrenal glands of
hypophysectomised rats, indicating possible involvement of the
pituitary-adrenocortical axis in adrenomedullary catecholamine release
in the rat.
The only piece of relevant work to come from the dog is by Wurtman et al
(»5b«)
(1968). Wurtman et _al h studied the release of adrenomedullary
catecholamines in response to insulin — induced hypoglycaemia and
interpreted their results solely with regard to changes in the synthesis
of adrenaline induced by corticosteroids. Their results, which are
expressed as percentage of adrenaline in adrenal venous plasma can be
recalculated to show both the resting output of adrenaline and
noradrenaline and also the release stimulated during insulin
hypoglycaemia. This reveals that corticotrophin in the
hypophysectomised dog increases the output of both adrenaline and
noradrenaline at rest and particularly during insulin hypoglycaemia.
This would support our findings whilst the potentiation of the release
during hypoglycaemia would suggest increased synthesis of adrenaline and
also noradrenaline by corticosteroids or alternatively that induction of
PNMT is secondary to release of adrenaline.
Evidence against involvement of the pituitary-adrenocortical axis in the
release of catecholamines from the adrenal medulla comes from work on
the conscious calf by Edward's group (Edwards et al (1975), Bloom et al
(1977a,b)). They have shown marked increases in hydrocortisone release
from the adrenal gland during mild hypoxia or hypercapnia without any or
only minimal catecholamine release respectively. This shows that
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hydrocortisone per se exerts no significant effect on catecholamine
release in the conscious calf. Henderson^(1980) investigated the
effects of infusing hydrocortisone to isolated feline adrenal glands and
reports no change in catecholamine output.
It is therefore possible that species differences exist in the
adrenomedullary response to corticosteroids.
In conclusion, there are two components to the response of the canine
adrenal medulla to carotid body hypoxia:- 1. The rapid component
dependent on an intact nerve supply to the adrenal gland but independent
of adrenocortical function, and 2. The delayed component requiring an
intact pituitary-adrenocortical axis but independent of the motor nerves
to the gland.
Also, in this series of experiments the degree of hypoxia induced was
less than that during short ""neural' chemoreceptor tests. Although I
have not investigated the threshold levels of hypoxia required to
release catecholamines either by neural or humoral mechanisms it is
possible that the humoral mechansim may have the lower hypoxic threshold
and could thus have the greater physiological significance.
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D. Effects of Indomethacin on Blood Pressure,
Catecholamine Release and Adrenal Blood Flow
in the anaesthetised, laparotomised dog
A problem we encountered in studying adrenomedullary reflexes was low
and poorly maintained blood pressures. The blood pressure fell
following laparotomy and handling of the viscera, necessary for
cannulation of the adrenal gland. Terragno et_ al (1977) reported
laparotomy to cause release of prostaglandins and that indomethacin,
given after laparotomy restores the blood pressure. In view of this
finding we gave indomethacin (5mg/kg), in divided doses to dogs before
and after laparotomy.
Results
Indomethacin treatment resulted in a mean blood pressure of about
lOOmmHg, the dogs requiring only small volumes of dextran to maintain it
for up to 3 hours. Without indomethacin a mean blood pressure of less
than 70mmHg resulted and large volumes of dextran were required to
maintain it. Indomethacin was therefore administered to several dogs to
maintain blood pressure.
Feuerstein et al (1979) reported that indomethacin increased the adrenal
output of catecholamines from the cat adrenal medulla in response to
haemorrhage. We therefore investigated the effect of indomethacin on
catecholamine release at rest and in response to baroreceptor tests.
We found catecholamine output at rest and the increased release during
baroreceptor tests to be reduced by indomethacin.
- 151 -
C.A. output Incremental output
at rest during baroreceptor tests.
Control 23.91 + 5.37 11.91 + 2.44
Indomethacin 4.31 + 0.55 3.35 + 0.68
(Catecholamines are expressed as ng kg ^min ^)
This is opposite to the findings of Feuerstein et al and is discussed."
^
In addition to the effects of indomethacin on blood pressure and
catecholamine release, we observed a reduction of adrenal blood flow at
rest and also a reduction of the increase which occurs following
chemoreceptor and baroreceptor tests. - This surprised us as the
increase in systemic blood pressure in response to baroreceptor and
chemoreceptor tests was if anything larger after indomethacin. We would
have anticipated a larger increase in adrenal blood flow to occur with
the larger rise in blood pressure.
To investigate this observation fully we constructed resting pressure-
flow curves for control and indomethacin treated dogs (see figure 15).
The data used to construct the curves, or more accurately regression
lines, is contained in tables 8 and 9.
Figure 15 shows the linear regression lines, with 95% confidence limits,
of adrenal blood flow on systemic blood pressure.
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TABLE 8
Resting Blood Pressure, Adrenal Blood Flow and
























19 68 3.45 7.68
66 3.20 14.24
64 3.50 24.16
20 55 2.93 21.60
69 3.30 18.10
66 2.50 18.00
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18 73 2.05 9.73
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Indomethacin produced a highly significant depression of the resting
pressure-flow curve. This suggests prostaglandins are involved in
maintaining adrenal blood flow.
The increases in adrenal blood flow observed during baroreceptor and
chemoreceptor tests would presumably be largely due to increases in
systemic blood pressure. To investigate the effect of indomethacin on
the relationship between catecholamine release and adrenal blood flow we
must first correct the changes in adrenal blood flow for any changes
occurring in systemic blood pressure. This is done using the resting
pressure-flow curves of figure 15.
The corrected flow changes are calculated thus:-
Change in flow = Actual flow change - (Pressure change x Gradient)
(corrected)
where gradient is the gradient of the relevant resting pressure-flow
curve.
In order to obtain accurate corrected flow values we require an accurate
measure of the change in systemic blood pressure. As the blood pressure
response to chemoreceptor tests is unstable and irregular (see figure
10) we used data obtained from only baroreceptor tests; where the
systemic blood pressure response is a regular vsquare wave'.
The regression lines with 95% confidence limits are presented in figure




Changes in Blood Pressure, Adrenal Blood Flow and
Catecholamine Release during Barotests in dogs not given indomethacin









6 BR 1 0.50 49 -1.57 9.12
BR 2 0.75 56 -1.61 16.32
7 BR 2 0.05 8 -0.29 1.89
BR 3 -0.25 16 -0.93 2.55
8 BR 1 0.75 41 -0.98 1.77
BR 2 1.20 44 -0.66 9.37
9 BR 1 1.00 38 -0.60 7.02
BR 2 1.25 42 -0.52 13.79
19 BR 1 1.30 87 -2.37 6.71
BR 2 0.95 66 -1.84 15.76
BR 3 1.50 59 -0.99 4.89
20 BR 1 1.11 47 -0.87 11.60
BR 2 0.66 47 -1.32 9.60
BR 3 1.22 58 -1.23 13.20
22 BR 1 0.75 56 -1.61 38.30
BR 2 0.70 64 -2.00 28.61
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TABLE 11
Changes in Blood Pressure, Adrenal Blood Flow and
Catecholamine Release during Barotests in dogs given indomethacin









10 BR 1 -1.05 122 -4.14 9.72
BR 2 0.75 106 -1.93 5.72
11 BR 1 0.30 83 -1.80 6.22
BR 2 -0.05 61 -1.59 0.90
12 BR 1 0.25 75 -1.65 5.61
BR 2 0.60 76 -1.32 4.44
13 BR 1 0.95 126 -2.24 3.04
BR 2 1.50 147 -2.22 6.16
14 BR 1 0.40 51 -0.89 0.17
BR 2 0.30 57 -1.14 1.88
16 BR 1 0.10 44 -1.01 1.48
BR 2 0.30 77 -1.65 1.82
BR 3 0.30 45 -0.84 3.10
17 BR 1 0.15 51- -1.14 0.88
BR 2 0.65 67 -1.05 2.29
18 BR 2 1.50 104 -1.13 0.13
- 158 -




















The results from figure 16 after indomethacin imply a marked
vasoconstriction associated with the release of catecholamines which is
not seen without indomethacin. This suggests prostaglandins are
normally released with catecholamines and maintain adrenal blood flow by
opposing their constricting action.
Statistical analysis using scatter plots reveals a heavy weighting of
one point used to construct the indomethacin regression line. (-4.14,
9.72 - from table 11). If this point is not used for the analysis then
a similar picture to figure 16 results but the separation of the two
regression lines is much less and significance can only just be claimed
at the 90% level. However, I have no reason to exclude this point. It
is unfortunate therefore that no other baroreceptor tests released
similar amounts of catecholamines to strengthen the analysis.
Effect of Synacthen infusion on blood pressure, catecholamine release
and adrenal blood flow
Three dogs (nos. 22-24) received a 25pg infusion of Synacthen.
In all dogs an increase in catecholamine release and adrenal blood flow
occurred without any increase in systemic blood pressure. This implies
ACTH directly increases adrenal blood flow. The increase could be
mediated by prostaglandins released with the catecholamines but this is
unlikely to completely explain it, as baroreceptor tests are unable to
show any increase in adrenal blood flow when pressure changes are
corrected for.
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Synacthen infusion was investigated in two dogs treated with
indometha'cin (nos. 18 and 19). However, the adrenal glands of these
dogs were rendered partly inactive and unreliable by attempted
denervation using lignocaine. (see ^Methods - Denervation of left
adrenal gland').
The Effect of Indomethacin on the release of PGI^ from the adrenal
medulla of the anaesthetised dog
The results are presented in full in Appendix 2, Dog no. 20.
In one dog, no. 20, prostaglandin 6-oxo-F^^, the stable metabolite of
PG^, was assayed, in addition to catecholamines, in adrenal venous
blood. PGI2 was also assayed in one arterial sample taken at the start
of the experiment.
The level of PG^ in the arterial sample was O.llng/ml.
As this is less than the concentration of PG^ found in adrenal venous
samples, PG^ is released from the adrenal gland.
Increases in PGI^ levels occur with increases in catecholamine release
during baroreceptor tests.
Indomethacin (5mg/kg) abolishes the increase in PG^ occurring during
baroreceptor tests but does not alter the increase in catecholamine
output.
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We attempted to assay PGE2 also, but the concentration of PGE2 was too
high, even after indomethacin, and we did not have enough sample left to
repeat the assay with a suitable dilution.
PGI2 was assayed by Nradio-immunoassay'.
The Effects of Indomethacin and PGE2 on catecholamine release from
isolated canine adrenal glands
A. The Effect of Indomethacin on catecholamine release stimulated by
nicotine
Indomethacin (lpag/ml) had no effect on the resting release of
catecholamines.
-5 -3
The adrenal response to infusions of nicotine (10 M - 10 M) was
variable. However, in two glands indomethacin appeared to reduce
the catecholamine release in response to nicotine whereas in one
gland the release appeared to be potentiated.
B. The Effect of PGE2 on catecholamine release
A PGE2 solvent blank produced no release of catecholamines. PGE2,
5-600ng/ml produced marked catecholamine release each time it was
infused. Although the response of the glands was again variable
evidence of a dose related effect was found (Gland no. 7).
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C. The Effect of Hexamethonium on catecholamine release stimulated by
—2
In this series of experiments PGE2 consistently increased
catecholamine output and was not blocked by hexamethonium.
Discussion
From the results in figure 15 it is clear that prostaglandins do play a
role in maintaining adrenal blood flow in the dog, under normal
conditions. If the results from figure 16 are accepted, although
statistical evidence for any difference after indomethacin is weak, then
it would appear that prostaglandins are released with increasing
concentrations of catecholamines and could have a role counteracting the
vasoconstriction associated with catecholamine release. In addition
prostaglandins may be inhibiting platelet aggregation, which is known to
occur in the presence of high concentrations of catecholamines such as
occurs in the adrenal vein. The results from dog 20 support this
hypothesis, as prostaglandin (PG^) release is found to increase with
catecholamine release. Catecholamines are also reported to release
prostaglandins from the kidney of the rabbit (Needleman et al (1974))
and the dog (Terashima et al (1974)). The release of PG's from the
rabbit kidney is inhibited by oQ - receptor blockade and this may be
involved in the mechanism of PG release from the adrenal gland.
However, PG release from the canine kidney is not ©C, blocked.
Rather than considering the effect of catecholamines on PG release most
authors have investigated the effects of PG's on catecholamine release,
as this is obviously much easier to do in the adrenal gland. My
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findings in the dog with indomethacin, a prostaglandin synthetase
inhibitor (Ferreira et al (1971)), indicate catecholamines would be
released by PG's. I have also supported this vin vitro', showing marked
catecholamine release from the isolated perfused canine adrenal gland in
response to infusions of PGE^.
Evidence has been produced of specific binding sites for PGE^ and PGE2
in the bovine, ovine and human adrenal medulla (Karaplis and Powell
(1981), Dazord et al (1974)) but I am unable to find any evidence of a
binding site in the canine adrenal medulla. However, in addition to my
own work Kayaalp and Tllrker (1967) have shown PGE^ to release
catecholamines from the adrenal medulla of the dog. The question of
whether PG's, particularly PG's of the E series, release or inhibit
catecholamine output from the adrenal medulla is still under debate. On
one hand Gutman and Boonyaviroj claim PGE2 inhibits, and indomethacin
potentiates, catecholamine release in human, (Boonyaviroj and Gutman
(1977)), rat (1975), bovine (1979) and feline (Feuerstein, Feuerstein
and Gutman (1979)) adrenal medulla. The mechanism of action of PGE2 is
claimed by them to be inhibition of adenyl cyclase (Gutman and
Boonyaviroj (1979)). Their findings agree with the hypothesis of
Hedqvist, who found PG's of the E series antagonised sympathetic
responses due to partial inhibition of noradrenaline release (Hedqvist
(1970), Hedqvist and Brundin (1969)) whereas PG-synthetase inhibitors
facilitate adrenergic responses and enhance noradrenaline release
(Hedqvist et al_ (1971), Samuelsson and Wennmalm (1971)). Hedqvist
concluded thfctPG's of the E series may limit noradrenaline release from
sympathetic nerves by a presynaptic inhibitory mechanism. However, much
of the data supporting this hypothesis is based on vin vitro' studies in
which isolated artificially perfused organs and artificial stimulation
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techniques are used. Also, in most studies, the release of tritiated
noradrenaline and not endogenous noradrenaline was measured. Whereas
Hedqvist's theory may be true for some sympathetic nerves it is not
substantiated in the sympathetic ganglia of the cat (Kayaalp and Mclsaac
(1968)). The ganglion is a site of cholinergic transmission similar to
the adrenal medulla and not adrenergic transmission as at sympathe-tic
nerve endings. I feel therefore that Hedqvist's work cannot really be
compared with the release of catecholamines from the adrenal medulla.
Whereas Gutman and Boonyaviroj claim PG's inhibit and indomethacin
potentiates catecholamine release from the adrenal medulla, other
workers have found the reverse to be true; in the rat (Feuerstein et al
(1981), (1982)), cat (1981) and human (Newman and Brodows (1982)).
Feuerstein, who has worked with Gutman, has published papers supporting
both argu ments from the one species, the cat. However, Feuerstein now
appears to be convinced that PG's do release catecholamines under a
variety of conditions and has criticised the earlier negative findings
as lacking any in vivo support.
Whilst the question remains unclear in some species, I have found no
reports suggesting PG's inhibit catecholamine release from the adrenal
gland of the dog. I therefore suggest that, in the dog, PG's of the E
series release catecholamines from the adrenal medulla whilst the PG-
synthetase inhibitor, indomethacin, inhibits release.
It is generally accepted that PGE2 and PGI2 cause vasodilation of blood
vessels. However, little work has been done to directly measure changes
in adrenal blood flow in response to PG's. What evidence there is
supports my finding that PG's produce an increase in adrenal blood flow.
- 165 -
Phernetton and Rankin (1979) have shown PG^ reduces adrenal vascular
resistance in maternal and foetal sheep. In addition to this Houck and
Lutherer have demonstrated indomethacin reduces adrenal vascular
resistance and blood flow in dogs. However, they found the adrenal
gland was able to maintain its blood flow during haemorrhagic
hypotension to 50mmHg, even in the presence of indomethacin. They
tested regulation of adrenal blood flow to haemorrhage under a variety
of conditions and concluded that the maintenance of adrenal blood flow
during haemorrhagic hypotension was independent of the autonomic nervous
system, prostaglandin synthesis, histamine recpetors and an intact
pituitary-adrenal axis. However, all these systems did influence
adrenal blood flow. - A possibility not investigated by Houck and
Lutherer was regulation by G.I.P., gastric inhibitory polypeptide.
There is some evidence to suggest that G.I.P., a compound similar in
structure to V.I.P., vasoactive intestinal polypeptide, has a
significant effect on adrenal blood flow in the dog at physiological
concentrations (Andersen et al (1982)).
The remaining evidence suggesting involvement of PG's in increasing
adrenal blood flow is indirect and comes largely from the work of Varga
et al, using ACTH and indomethacin. They found ACTH produces increases
in both adrenal and ovarian blood flow in the dog which is blocked by
indomethacin. (Varga et al (1976, 1978, 1979), Stark and Varga (1975),
Horv&th et al (1981)). My results support their finding that ACTH
increases adrenal blood flow but unfortunately I was unable to test the
response in the presence of indomethacin owing to damaged preparations
(see vResults').
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Stark et al^ (1965, 1968) found the ACTH induced increase in adrenal
blood flow continued even after corticosteroid increase had ceased.
However, cycloheximide was found to block both the increase in adrenal
blood flow and steroidogenesis in response to ACTH. The two responses
were not considered to be related as steroidogenesis ceased some 2 hours
before cycloheximide had any effect on adrenal blood flow.
PGE^ has also been shown to stimulate corticosteroidogenesis (Louis ert
al, (1976), Flack et al (1969), Saruta and Kaplan (1972)) and it has
been suggested that PGE^ is involved in mediating ACTH induced
steroidogenesis as well as increases in adrenal blood flow. As PGE2
appears to induce steroidogenesis and increase corticosteroids, it is
possible that part of the adrenomedullary response to PGE^ is mediated
by corticosteroids; as corticosteroids have been shown to increase
catecholamine release from the canine adrenal medulla (Critchley .et al
(1975)). Whilst corticosteroids may mediate part of the PGE^ induced
catecholamine release they certainly do not mediate it all, as I have
found PGE2 retrogradely infused to the canine adrenal gland, thus
avoiding any cortical influence, still produces marked increases in
catecholamine release. Nonetheless , an action of PGE2 on
catecholamine release mediated by corticosteroids vin vivo7 cannot be
excluded.
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Summary of Results
1. Hexamethonium bromide produces small but consistent increases in
the percentage of noradrenaline released at rest.
2. No other evidence of selective release was found. The ratio of
noradrenaline:adrenaline remained constant at 1:3.5.
3. Hexamethonium bromide significantly inhibits the adrenal response
to both baroreceptor and chemoreceptor tests. The inhibition is
consistently greater during baroreceptor tests.
4. (-)Hyoscine methyl bromide significantly inhibits the adrenal
response to both baroreceptor and chemoreceptor tests but to a
lesser extent than hexamethonium. The mean inhibition of the
chemoreceptor test was the greater.
5. Hexamethonium bromide and hyoscine methyl bromide in combination
abolish any adrenal response to baroreceptor and chemoreceptor
tests.
6. Both nicotinic and muscarinic receptors are involved in the
transmission of the baroreceptor and chemoreceptor reflexes to the
adrenal medulla. Some selectivity of the baroreceptor and
chemoreceptor reflexes for nicotinic and muscarinic receptors
respectively is shown.
7. The release of catecholamines from the adrenal medulla in response
to carotid body hypoxia may outlast the stimulus.
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8. After denervation of the adrenal gland the immediate release of
catecholamines in response to carotid body hypoxia is abolished,
but the prolonged release remains.
9. The prolonged release of catecholamines is abolished by
cycloheximide.
10. Denervated glands in combination with cycloheximide do not release
catecholamines in response to carotid body hypoxia.
11. Corticotrophin markedly increases catecholamine release from the
adrenal medulla.
12. Indomethacin maintains systemic blood pressure following
laparotomy.
13. Indomethacin inhibits catecholamine release both at rest and during
baroreceptor tests.
14. Prostaglandin releases catecholamines from the isolated perfused
canine adrenal gland.
15. Prostaglandin I^ is released from the adrenal gland of the dog
during baroreceptor tests and at rest. Indomethacin abolishes
release.
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16. Indomethacin depresses the resting pressure-flow curve of the
adrenal gland and inhibits the rise in adrenal blood flow which
occurs during baroreceptor and chemoreceptor tests.
17. Corticotrophin (Synacthen) increases adrenal blood flow without any
increase in systemic blood pressure.
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Conclusions
The canine adrenal medulla does not selectively release adrenaline
or noradrenaline in response to chemoreceptor or baroreceptor
reflex stimulation, as found in the cat. If selective release of
catecholamines occurs at all in the dog, the changes in the
noradrenaline:adrenaline ratio are so small that they are difficult
to detect.
Transmission of the baroreceptor and chemoreceptor reflex to the
adrenal medulla of the dog consists predominently of nicotinic
receptor activation with a large subsidiary muscarinic component.
There is some evidence to suggest selectivity of the baroreceptor
reflex for nicotinic receptors and the chemoreceptor reflex for
muscarinic receptors. - This is not conclusive.
There are two components to the response of the adrenal medulla to
arterial chemoreceptor stimulation.
a) A rapid component requiring an intact nerve supply to the
adrenal gland but independent of adrenocortical function, and
b) A delayed component requiring an intact pituitary -
adrenocortical axis but independent of the motor nerves to the
gland.
Prostaglandins play a role in maintaining adrenal blood flow in the
dog. - I would also suggest prostaglandins are released with
catecholamines and maintain adrenal blood flow by opposing the
constrictor action of the catecholamines.
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5. Prostaglandin E£ releases catecholamines from the canine adrenal
medulla. Whether this will prove to have any physiological
significance remains to be determined.
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Appendix 1
The Assay of Hydrocortisone in Adrenal Venous Plasma
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Introduction:-
Previous workers in this laboratory have implicated hydrocortisone in
the release of catecholamines from the canine adrenal gland, especially
in situations of prolonged stimulation of the arterial chemoreceptors.
(Critchley and Ungar (1974), Critchley, Henderson, Moffat, Ungar, Waite
and West (1975)). As I continued the investigation into the humoral
control of catecholamine release from the adrenal medulla I decided it
would be useful to assay adrenal venous blood, not only for
catecholamines, but also for hydrocortisone.
Selection of Technique
Three different methods for the assay of plasma hydrocortisone are
currently in use:- Colorimetric, fluorimetric and competitive protein
binding radioassay. The colorimetric or Silber-Porter procedure (see
Peterson, Karrer and Guerra (1957) )- does not correlate well with results
from other techniques. (Mejer and Blanchard (1973)). The colorimetric
method measures 17-hydroxy-corticosteroids and the higher values this
technique yields for plasma hydrocortisone may be caused by other
substances in plasma which do not affect fluorimetric methods, e.g.
ketones.
The competative protein binding assay is highly specific for
hydrocortisone and is undoubtedly the method of choice. (Murphy (1967),
Nugent and Mayes (1966), Few and Cashmore (1971), Malinowska, Hardy and
Nathanielsz (1972)). However, our laboratory was not equipped
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to make use of this type of assay. Therefore, as second choice, we
selected the fluorimetric assay of hydrocortisone. Fluorimetry is a
well established technique in our laboratory as it is used routinely for
the assay of adrenaline and noradrenaline. Therefore, little effort was
entailed in setting up the fluorimetric procedure for hydrocortisone.
The fluorimetric assay of hydrocortisone
The quantitative determination of adrenal 11-hydroxy-corticosteroids
from the fluorescence induced by ethanolic sulphuric acid was first
demonstrated by Sweat (1954). Since then many modifications have been
introduced, resulting in publication of a variety of different methods,
e.g. Silber, Busch and Oslapas (1958), Guillemin et al (1958), Mattingly
(1962), DeMoor et al (1970), Kitabchi and Kitchell (1970), Meyer and
Blanchard (1973)). For easier reading Rubin (1970) has summarised most
of the modifications.
' (WJ)
We selected the method of Meyer and Blanchard^; as their assay offered
the simplest procedure, with sensitivity, accuracy and specificity equal
to that of any of the other methods. Meyer and Blanchard's procedure is
OVo)
based on the method of Kitabchi and Kitchell, which they have simplified
by eliminating centrifugation, processing samples consecutively and by
in
prealkal^izing standards, blanks and plasma standards.
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Experimental Protocol for Hydrocortisone Assay
Adrenal venous sample
Adrenal venous blood is collected and the plasma separated and
stored (see xExperimental Protocol for Catecholamine Assay').
Extraction procedure
The plasma is thawed and the fibrin resuspended and mixed to ensure
even distribution.
0.5.ls plasma is transferred to a 15ml stoppered tube. (The
remainder of the sample is stored for subsequent catecholamine
estimation).
Samples are processed at 1 minute intervals.
1. Add 50pl of 0.25M Sodium hydroxide to the plasma.
2. Whirly-mix for 10 seconds.
3. After 4.5 minutes add lOmls of dichloromethane.
4. Whirly-mix for 25 seconds.
5. Centrifuge at 3000r.p.m. for 2 minutes to ensure phase
separation.




1. Add 4mls of vfluorescence reagent' (see notes on assay) to the
6mls of organic phase.
2. Whirly-mix for 10 seconds.
3. After phase separation is complete (about 10 minutes) discard
the upper organic phase and transfer the lower alcoholic phase
to an appropriate cuvette or tube which will fit the
xAminco-Bowman Spectrophotofluorimeter'.
4. 45 minutes after the addition of the Nfluorescence reagent'
the fluorescence is read in the spectrophotofluorimeter. The
emission wavelength is fixed at 530mp and the excitation
wavelength scanned from 400nyu to scatter at about 530mp. The
peak fluorescence is recorded at excitation wavelength 470mp.
Blanks
Reagent blanks are run by substituting 0.5ml of distilled,
deionised water for plasma.
Standards
Stock solution:- Hydrocortisone (lOjig/ml) is dissolved in absolute
ethanol and stored at 4°C.
Working standards of l^ig/ml are made from the stock solution by
diluting with distilled, deionised water.
- 177 -
0.5ml of the working standard is substituted for plasma and assayed
accordingly.
Plasma standards are also run by adding stock solution to plasma
and comparing with plasma without stock solution added.
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Notes on the Hydrocortisone Assay
Volume of plasma used
OlS)
Mejer and Blanchard used 1ml of plasma for their assay of serumA
11-hydroxycorticosteroids. As I am assaying adrenal venous blood
and corticosteroid levels are higher only 0.5ml of plasma has been
used.
Tubes used in assay
Stoppered tubes are essential to prevent spillage during mixing as
large volumes are used. This is particularly important when mixing
the fluorescence reagent as it is highly acidic and burns when in
contact with skin.
Sodium hydroxide reagent —
Prealkalinization eliminates non-cortisol fluorescence from the
sample without affecting the 11-hydroxycorticosteroids (Nielsen and
Asfeldt (1967), Mejer and Blanchard (1973)). The concentration of
sodium hydroxide used is the same for the method of Mejer and
Ol>3)
Blanchard. Mejer and Blanchard demonstrated that further increaseJ
A,
in the concentration of sodium hydroxide did not reduce
fluorescence. Also, prealkalinization times of 0 to 15 minutes
produced no significant variation in fluorescence.
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Centrifugation to phase separate
Cw>o)
Kitabchi and Kitchell^introduced phase separating filter paper as a
time saving device to separate the aqueous plasma phase from the
organic extraction phase. As we did not have phase separating
filter paper available when setting up the assay, a short spin in a
bench centrifuge and careful removal of 6mls of organic phase,
through the aqueous phase, was tried and found adequate. In fact,
the filter paper contributes to the reagent blank value. When
removing the organic phase particular attention must be paid to
ensure that the extract remains free from moisture; thus avoiding
the possible problem of spurious hydrocortisone values as a result
of moisture uptake during extraction. (DeLange and Whittlestone
(1970)).
Fluorescence reagent
The fluorescence reagent comprises 6.5 volumes of sulphuric acid to
3.5 volumes of absolute ethanol.
To combine these reagents they are first cooled to A°C and the
concentrated sulphuric acid added slowly to the absolute ethanol,
immersed in a bath of alcohol and dry ice to prevent the
temperature exceeding 25°C.
This is a hazardous procedure and great care must be taken when
synthesising this reagent.
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The fluorescence reagent is very stable (2 months at 37°C) but does
discolour with time. The reagent was stored at 4°C and renewed
every 2 months or as required.
Reading of fluorescence
Mejer and Blanchard^examined the development of fluorescence with
time. They found fluorescence took about 30 minutes to develop and
was stable up to 1 hour. We therefore read the fluorescence at 45
minutes, the mid-point of the plateau in the fluorescence/ time
curve. I found there to be no change in fluorescence when the
reading was taken 5 minutes either side of this point.
In agreement with Koch, Edwards and Chilcote (1973) I find the
fluorescence maxima for excitation and emission to occur at 470 and
Cmi)
530mu respectively. Koch et_ al also found the minimum interference
from non-specific fluorophors to occur at these wavelengths.
Therefore, 470/530mp is used for reading fluorescence rather than
017S)
470/520mjLi as used by Mejer and Blanchard^. An example of the
typical fluorescence spectra of a sample is presented (figure 17).
Linearity of assay
The linearity of the assay was checked by assaying known standards
of hydrocortisone in the range 20ng to 2jig. Working standards and
plasma standards were compared and no difference was found.
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Concentrationofhydr cortisone(jug)
The results obtained using plasma standards are presented in Figure
18.
I did not pursue the assay to its limit of sensitivity as the
levels of corticosteroids in the samples assayed were high;
however, Mejer and Blanchard claim that a standard of 5ng
consistently gives fluorescence values higher than the reagent
blank, when a spectrophotofluorimeter is used. (If a filter type
fluorimeter is used lOng is the limit of sensitivity).
Specificity
Ow)
Mejer and Blanchard have published a paper studying the specificity
A
of their method. They identified four principal contaminants in
the hydrocortisone containing extract of human plasma. These were
corticosterone, triglyceride, cholesterol and non-specific
fluorogens. Of the total fluorescence measured an average of 62%
was due to hydrocortisone, 29.9% to corticosterone and 9.9% to the
remainder. - This appears no less specific than any other
fluorimetric technique available. In adrenal samples the level of
hydrocortisone, and also corticosterone, is higher than in
peripheral samples; therefore I would expect the other plasma
fluorogens to contribute relatively less to the total fluorescence.
Although hydrocortisone is the principal corticosteroid released
from the adrenal gland corticosterone is also released in
measurable quantities. The fluorescence spectra of these two
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compounds are indistinguishable and the fluorescence intensity per
microgram of corticosterone is about five times that of
hydrocortisone. This implies the assay is only valid if the ratio
of corticosterone to hydrocortisone remains constant. As I was
aware of no evidence from the dog indicating selective release, the
assay was used; but with reservations.
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Results
11-Hydroxy-corticosteroids were measured in adrenal venous blood samples
from twelve dogs. The results from each animal are reported in Appendix
2. vTables of Results from Whole Animal Experiments'.
Of the twelve, dogs, from which samples were assayed for 11-hydroxy-
corticosteroids, four were given an infusion of Synacthen (Ciba) with no
other drug present; one receiving 250jig and the others 25jig.
Synacthen, (tetracosactrin acetate), is a synthetic analogue of
corticotrophin (ACTH), l^ig equivalent to about 1 I.U. of ACTH,
possessing the complete therapeutic activity of cortioctrophin and
indistinguishable from it in its action. Synacthen (25pg) would
therefore be expected to produce a marked increase in adrenal venous
hydrocortisone levels as has been shown with ACTH, e.g. Marotta, S.F. et_
al(l97^. This however is not the case.
The resting levels of adrenal venous hydrocortisone lie within the range
of published figures but, at best, only a modest and transient increase
in hdyrocortisone occurs with Synacthen infusion.
As Synacthen is used clinically to test adrenal-cortical function and
ACTH is known to release hydrocortisone from the canine adrenal cortex I
must express doubt as to the reliability of the assay I have used.
A possible explanation of poor hydrocortisone release could lie in the
differing fluorescence intensity produced by hydrocortisone and
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corticosterone; (see vNotes on the Hydrocortisone Assay - Specificity')
such that a five unit increase in hydrocortisone accompanied by a one
unit decrease in corticosterone would produce no change in total
fluorescence, and thereby no change in measured corticosteroid. This
explanation is doubtful as ACTH is reported to increase corticosterone
levels as well as hydrocortisone; in fact, increased corticosterone has
been used, in the rat, as an indicator of increased ACTH release, e.g.
Stark, E. et aJ. (1970). Also, Marotta and co-workers, a leading group
in the study of adrenal corticosteroids, have used both the
17-hydroxy-corticosteroid colorimetric method (which does not measure
corticosterone) and the 11-hydroxy-corticosteroid fluorimetric method
and reported no obvious differences.
If the assay is valid then either the adrenal cortex of the dogs used
were insensitive to Synacthen or were too depleted of corticosteroids,
through surgical stress, to respond normally. The latter explanation
may be true as resting corticosteroid levels, although within the
published range for anaesthetised dogs, lie close to the lower limit of
the range.
Owing to the dubious nature of the results obtained I have not used the
corticosteroid figures to draw any conclusions and have presented the
assay as an appendix rather than part of the main text.
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Appendix 2




























() indicates the indomethacin was given during the
experiment rather than before.
Hexamethonium Bromide.
(-) Hyoscine Methyl Bromide.
() indicates which of HEX and HYO was administered
second.
Adrenocorticotrophic Hormone (Synacthen).
Catecholamine estimation (Adrenaline and Noradrenaline)
Hydrocortisone (11-hydroxy-corticosteroids).
Prostaglandin-6-0X0-F^^
refers to sample number
Partial gas pressures in mmHg.
Carotid perfusion pressure.
Mean systemic blood pressure.
Catecholamines (Adrenaline + Noradrenaline)
Baroreceptor test.
Chemoreceptor test.
Sample collection immediately following CR.
Long chemoreceptor test.
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1 + 1 1 1 + (+)| 1 + |
2 + 1 1 1 + 1 1 + |
3 + 1 1 1 (+) + | 1 + |
4 + 1 I 1 (+) + | 1 + |
5 + 1 1 1 + | 1 + |
6 + 1 1 1 + (+)| 1 + |
7 + 1 1 1 + | 1 + |
8 + 1 1 1 1 1 + |
9 + 1 1 1 + 1 1 + |
10 + 1 1 | + + | 1 + |
11 + 1 1 | + + 1 1 + |
12 + 1 1 | + + | 1 + |
13 + 1 1 | + + 1 1 + |
14 + 1 1 | + + 1 1 + |
15 + 1 1 | + + 1 1 + |
16 + | + (+) + | 1 + |
17 + 1 1 | + + 1 1 + |
18 + + 1 1 | + 1 + | + | +
19 + + 1 1 |(+) 1 + | + | +
20 + 1 1 |(+) 1 1 + |
21 + 1 1 1 1 + | + | +
22 + + 1 1 1 1 + | + | +
23 + + | FAILED | 1 1 + | + | +
24 + 1 ' 1 1 + | + | + | +
25 + 1 1 1 + + | + | + | +
26 + + | FAILED | 1 + + | + | + | +
27 + + 1 + 1 1 1 1 + | +
28 + + 1 + i 1 1 1 + | +
29 + + 1 + 1 1 1 1 + | +
30 + + 1 + 1 + 1 1 1 + |
31 + + 1 + 1 + 1 1 1 + |
32 + + | FAILED | + 1 1 1 + |
33 + + | FAILED | 1 1 1 + | +
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10 12.5 21 23.5 30 32.5 38 51 53.5 60 62.5 74 76.5 83 85.5









33.0 36.5 50.0 33.5 35.5 58.0 30.0 60.0 30.0 28.0 45.0
















65 95 ETHONIUM 60 80 66 104 53 69 51 62
28.43 35.45 24.13 18.90 19.82 33.61 20.83 22.03 (lOmg/kg) 0.43 0.17 0.00 0.80 0.16 0.16 0.48 0.64
20 18 15 15 22 20 16 14
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Tables of Results from Isolated Adrenal Gland Experiments
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Effects of indomethacin on blood pressure,
catecholamine release and adrenal blood flow
in the anaesthetized, Iaparotomized dog
P. ELLIS & A. UNGAR
Department of Pharmacology, University of Edinburgh,
1 George Square, Edinburgh EH8 9JZ
A problem in studying adreno-medullary reflexes is
the massive fall in blood pressure following
laparotomy and handling of the viscera. Terragno et
al. (1977) reported that laparotomy causes release of
prostaglandins and that indomethacin, given after
laparotomy, restores the blood pressure. We gave
indomethacin (5 mg/kg) in divided doses to dogs
before and after laparotomy. This enabled us to
a)
maintain a mean blood pressure around lOOmmHg
for up to 3 h, whereas without indomethacin it was
difficult to maintain a blood pressure of 70 mmHg.
In contrast to Feuerstein et al.'s (1979) results in
the cat, indomethacin did not affect the amounts of
adrenaline or noradrenaline released at rest or in
response to chemoreceptor or barareceptor stimula¬
tion. Indomethacin did however reduce both the
resting adrenal blood flow and the increase in blood
flow during the reflex release of catecholamines.
The depression of the resting pressure flow curve
(see Figure la) suggests the involvement of prostag¬
landins in maintaining adrenal blood flow. Figure lb
was derived using these curves to correct the flow
changes accompanying the reflex rise in blood pres¬
sure. The results in Figure lb after indomethacin







Blood pressure (mmHg) AFLOW (mis mini4)
(Corrected for pressure change)
Figure 1 a) Resting pressure flow curves for left adrenal gland with and without indomethacin. b) Regression of
change in adrenal flow (corrected for pressure from Figure la) on catecholamine release. All lines show 95%
confidence limits.
release of catecholamines which is not seen without
indomethacin. This suggests that prostaglandins are
released with catecholamines and maintain adrenal
blood flow by opposing their constricting action. This
may also explain why platelet aggregation due to high
concentrations of catecholamines does not occur in
adrenal veins.
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THE REFLEX RELEASE OF ADRENALINE AND NORADRENALINE
FROM THE ADRENAL GLANDS OF CATS AND DOGS
BY J. A. J. H. CRITCHLEY, P. ELLIS AND A. UNGAR
From the Department of Pharmacology, University of Edinburgh,
1 George Square, Edinburgh EH8 9JZ
(Received 3 May 1979)
SUMMARY
1. We have studied the release of noradrenaline and adrenaline from the adrenal
glands of dogs and cats in response to the lowering of carotid sinus pressure (baro-
receptor tests) and to the perfusion of the vascularly isolated carotid bifurcations
with hypoxic blood (chemoreceptor tests).
2. In cats, the resting output of catecholamines had a ratio of noradrenaline to
adrenaline of 1:1. The ratio in the incremental release during baroreceptor tests
rose to 3:1, and during chemoreceptor tests it fell to 1:6.
3. In dogs, the ratio of noradrenaline to adrenaline at rest was 1:4. The ratio
did not change over a wide range of outputs during baroreceptor tests, chemoreceptor
tests and splanchnic nerve stimulation.
4. The release of catecholamines in response to baroreceptor tests in the cat was
abolished by hexamethomium bromide at doses that did not diminish the response
to chemoreceptor tests.
INTRODUCTION
In both the cat and the dog the adrenal glands release a mixture of adrenaline
and noradrenaline into the bloodstream (Holtz et al. 1947; Bulbring & Burn, 1949).
Many authors have argued for and against the independent control of the release of
the two catecholamines. If one discounts work based on estimates of catecholamines
in peripheral blood, where noradrenaline circulates from sympathetic adrenergic
endings as well as from the adrenal glands, most of the evidence in favour of indepen¬
dent control comes from work on the cat (Von Euler & Folkow, 1953; Folkow &
Von Eider, 1954; Duner, 1953), while most of the evidence against comes from work
on the dog (Malmejac, 1964).
No direct comparison has been made between the two species, using similar
techniques of stimulation, collection and assay. We therefore set out to apply to
cats and dogs reflex stimuli that should, on the basis of previous work, preferentially
release adrenaline or noradrenaline, and to assay both in the venous effluent of an
adrenal gland.
Anichkov, Malyghina, Poskalenko & Ryzhenkov (1960) compared the effect of
carotid occlusion with that of cyanide injection in cats. They found that the former
produced a relatively greater vasoconstriction in a denervated hind limb, while the
latter produced relatively greater contraction of a denervated nictitating membrane.
0022-3751/80/6440-0189 $07.50 © 1980 The Physiological Society
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These results suggest that the baroreceptor reflex may preferentially control
noradrenaline release, and the chemoreceptor reflex preferentially control adrenaline
release. We have therefore used baroreceptor and chemoreceptor stimuli to test the
adrenal gland for independent release of adrenaline and noradrenaline.
A preliminary account of part of this work has been published (Critchley, Ungar
& Welburn, 1973).
METHODS
Anaesthesia. Dogs were anaesthetized with an i.v. injection of chloralose (55 mg/kg) and
urethane (550 mg/kg) or of sodium pentobarbitone (30 mg/kg) (see Discussion). Cats were
anaesthetized with an I.e. injection of sodium pentobarbitone (40 mg/kg). In both species
anaesthesia was maintained by continuous i.v. infusion of the anaesthetic agent at a rate of
about one tenth of the initial dose per hour, adjusted so as just to suppress the paw withdrawal
reflex.
Respiration, acid base balance and temperature control. The trachea was cannulated and
connected to a Starling 'Ideal' pump. The lungs were ventilated with a metered oxygen-
nitrogen mixture so as to hold Pa Co, at ® kPa in dogs and at 4 kPa in cats, and I\ 0, above
20 kPa in both species, measured from frequent arterial blood samples on a Radiometer BMS 3
analyser. A molar solution of sodium bicarbonate was injected after each sample to hold the
arterial plasma pH at 7-4. Body temperature was held near to 37 °C by a heating pad linked to
a rectal thermistor probe.
Carotid perfusion. Both common carotid arteries were cannulated both ways and blood
from one of them was perfused into both towards the head, by a Watson Marlow MHRE pump.
Both superior thyroid, internal carotid and external carotid arteries were ligated, and any other
branches between the point of cannulation and the origins of the lingual arteries. Only the lingual
arteries were left open to maintain an adequate flow through the system and thus allow changes
in blood composition to affect the carotid bodies rapidly.
A pressure transducer was connected to the perfusion circuit. The signal was passed through
a servo amplifier to the perfusion pump so that perfusion pressure could be set and held constant.
Stimulation of reflexes. Tests were performed, and the method evaluated as described by
Henderson & Ungar (1978). Baroreceptor tests consisted of a lowering of carotid perfusion
pressure from a constant resting level, while the l\ Gj of the perfusing blood was held high.
Chemoreceptor tests consisted of a lowering of the R, 0j of the perfusing blood, at constant
perfusion pressure, while infusing into it a 1 h solution of sodium dithionite at a rate of about
150mg/min (Critchley & Ungar, 1975). The duration of each test was 60s in dogs and 120s
in cats.
The systemic arterial blood gas tension did not change whilst sodium dithionite was infused
into the carotid circuit. In two dogs the application of lignocaine to both carotid sinus nerves
completely abolished the vascular and respiratory responses to baroreceptor and chemo¬
receptor tests.
Both vagosympathetic trunks were cut in the neck in order to abolish secondary reflexes
from thoracic receptors.
Collection of adrenal venous blood. In the dog, the left adrenolumbar vein was cannulated
towards the gland, and the venous outflow collected into refrigerated heparinized tubes after
ligation of the adrenal vein.
In the cat, cannulation of the adrenolumbar vein creates too great a back pressure on the
gland. We therefore made a closed sac of the main vein into which the left adrenal gland drained:
either the left renal vein or the inferior vena cava. The sac was bypassed by a silicone rubber
tube. Adrenal venous blood was collected from the sac by a double-lumen cannula, the dead
space of the sac being washed through by perfusing 10% sucrose solution at 4 ml min-1.
Estimation of catecholamines. Adrenal venous blood was collected in centrifuge tubes con¬
tainingmeasured volumes of 19% sucrose solution with EDTA 5 g/1 and immediately centrifuged
at 4 °C. The use of sucrose instead of salt was found to reduce the centrifugation time. The
volumes of supernatant and of packed cells were recorded.
The samples were loaded onto Amberlite CG120 columns (mesh 100-200, length 20 mm,
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diameter 2-5 mm). They were rinsed with 20 ml EDTA solution, 1 g/1, 2-5 ml phosphate buffer
pH 6-5 and finally with 5 ml water. They were eluted with 4 ml M-hydrochloric aeid and stored
at 0 °C.
Trihydroxyindole derivatives were prepared by the method of Yendsalii (1960) with minor
modifications (Critchley, 1976). This method gave an index of discrimination between adrenaline
and noradrenaline of 8. Replicate estimates of plasma containing 5 nmol catecholamine/1 gave
a standard deviation of 0-5 nmol/1. The recovery of standards in plasma was 90%.
Analysis of results. The statistical significance of results was assessed by the paired t test.
Drugs. Chloralose and urethane (B.D.H. chemicals); sodium pentobarbitone (Abbott) and
hexamethonium bromide (Koch Light).
RESULTS
Resting levels. The mean outputs of noradrenaline and adrenaline from the left
adrenal glands of five dogs under chloralose (eighty-three samples) and seven cats
(thirty samples) at rest are shown in Table 1. In the dog, noradrenaline and adrenaline
were released with a ratio of about 1:4, and a mean total output of 77 pmol min-1
kg body wt-1. In the cat, the ratio was 1:1 with a mean total output of 35 pmol
min-1 kg body wt_1. In a further three dogs under pentobarbitone anaesthesia the
ratio was again 1:4, with a mean total output of 48 + 8 pmol min-1 kg body wt-1.
Baroreceptor and chemoreceptor tests. The results are shown in Table 1. Baro-
receptor and chemoreceptor tests in both species gave two to threefold increases in
catecholamine output. In the dog, there was no change in the ratio of noradrenaline
to adrenaline during either of the reflex responses. In the cat, on the other hand, the
ratio of noradrenaline to adrenaline rose from 1:1 to 3:1 in the increment over
control output during baroreceptor tests, and fell from 1:1 to 1:6 in the increment
over control output during chemoreceptor tests. These changes are statistically
significant (P < 0-01).
The effect of magnitude of response on the ratio of catecholamines released. In both
dogs and cats we investigated the effect of varying the intensity of chemoreceptor
and baroreceptor tests on the ratio of noradrenaline to adrenaline released. The
results are shown in Fig. 1 in the form of a regression analysis of ratio on total
release. Over a more than fivefold range of rate of release in each group, the ratio
in cats rose significantly above the resting ratio during baroreceptor tests, and fell
significantly below it during chemoreceptor tests. In dogs the ratio remained fixed
throughout the ranges of both stimuli.
Tests on dogs under pentobarbitone anaesthesia. In view of the possibility that the
selective release of noradrenaline and adrenaline could be due to anaesthetic rather
than species differences, we carried out baroreceptor and chemoreceptor tests on
five dogs under pentobarbitone anaesthesia. In six baroreceptor tests, in which the
carotid sinus pressure was lowered from 120 to 90 mmHg, the mean total catechola¬
mine output rose from 48 + 8 to 105 + 15 pmol min1 kg-1. In six chemoreceptor
tests the mean total catecholamine output rose from 48+8 to 80 + 41 pmol min-1
kg-i. The ratio of noradrenaline: adrenaline at rest was 0-25 + 0-3, during baro¬
receptor tests was 0-22 + 0-03 and during chemoreceptor tests was 0-20 + 0-03.
Thus qualitatively the reflex responses of dogs under chloralose and under pento¬
barbitone were similar. Quantitatively the adrenal medulla was more responsive to
baroreceptor tests under pentobarbitone than under chloralose. The responses to
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chemoreceptor tests, however, were substantially but variably inhibited by pento¬
barbitone. Except in one dog, lowering of the carotid perfusate PQi to between 4 and
5 kPa did not release catecholamines, although strong respiratory and vascular
responses were obtained with stimuli of this intensity, but release was obtained in

















Fig. 1. The relationship between total catecholamine release and the ratio of noradrena¬
line to adrenaline. Regression lines of noradrenaline: adrenaline on total release. Con¬
tinuous lines represent resting release, dashed lines release during baroreceptor tests,
and dashed-dotted lines release during chemoreceptor tests. The upper graph
represents results on five cats, with fifteen resting levels, nine chemoreceptor tests and
twelve baroreceptor tests. The lower graph represents results in five dogs with thirty
resting levels, fourteen chemoreceptor tests and fourteen baroreceptor tests. For each
line the range of total release is greater than 5:1. The lines for chemoreceptor tests and
baroreceptor tests in cats show 95 % confidence limits. Note that the scale of the
ordinate for dogs is 10 times that for cats.
The effect of hexamethonium bromide on baroreceptor and chemoreceptor tests. In
three cats, we carried out baroreceptor and chemoreceptor tests before and after
i.v. injection of hexamethonium bromide (2 mg/kg body wt). The mean resting
output of catecholamines was 36 + 4 pmol min-1 kg~h This rose by 38+17 pmol
min-1 kg-1 during baroreceptor tests and by 22 + 11 pmol min-1 kg-1 during chemo¬
receptor tests. After administration of hexamethonium bromide the resting output
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was 14+3 pmol min-1 kg-1. The output now rose by 0-05 ± 2 pmol min-1 kg-1 during
baroreceptor tests, and by 41 + 21 pmol min-1 kg-1 during chemoreceptor tests. The
response to chemoreceptor tests was thus undiminished by a dose of hexamethonium
bromide that abolished the response to baroreceptor tests.
Electrical stimulation of the greater splanchnic nerve. In three dogs fifteen tests of
electrical stimulation of the greater splanchnic nerve were performed. During
stimulation, the mean output of noradrenaline rose by 224 + 63 pmol min-1 kg-1,
and that of adrenaline by 712 + 190 pmol min-1 kg-1, giving a ratio not significantly
different from that in the resting output.
DISCUSSION
Anaesthesia. The choice of anaesthetic agents was a major problem. We found
that in cats under pentobarbitone we were able to obtain balanced adrenal responses
to chemoreceptor and baroreceptor tests, from a low resting level. Cats under
chloralose have high resting outputs with a high ratio of noradrenaline to adrenaline
(Kaindl & Von Euler, 1951) and also show selective depression of baroreceptor
responses in contrast to chemoreceptor responses (Neil, Redwood & Schweitzer,
1949).
In dogs on the other hand we obtained balanced responses under chloralose to
stimuli of the same order of intensity as those required in cats under pentobarbitone.
In dogs under pentobarbitone, the chemoreceptor response was strongly inhibited in
relation to the baroreceptor response. By using stronger stimuli we were nevertheless
able to exclude any shift in the ratio of noradrenaline to adrenaline in the adrenal
effluent of dogs with either stimulus under pentobarbitone anaesthesia. The differ¬
ences between dogs and cats in our experiments are not due to differences in
anaesthesia.
Resting levels and size of responses. Our resting outputs of catecholamines in the
dog are similar to those reported by previous workers who took similar precautions
to avoid excessive blood loss or hypoxia (Rapela & Houssay, 1952; De Schaep-
dryver, 1959). Our resting levels in the cat are similar to those reported by Feurstein
& Gutman (1971) for cats under pentobarbitone anaesthesia.
The size of our reflex responses is similar to that obtained by De Schaepdryver
(1959) with carotid occlusion, but far smaller than those found by other workers
using more massive stimuli such as haemorrhage and asphyxia (Rapela & Houssay,
1952). The responses to electrical stimulation show that our preparations are capable
of maximal outputs of catecholamines far greater than their reflex responses to
discrete sensory stimuli.
Selective release of noradrenaline and adrenaline. Our results in the cat provide
direct confirmation for the conclusion of Anichkov et al. (1960) that the arterial
baroreceptors selectively control noradrenaline output from the adrenal glands
while the arterial chemoreceptors selectively control adrenaline output. Since we
are dealing with concentrations of catecholamines in the adrenal venous effluent,
there is no question of our results being confused by noradrenaline circulating from
peripheral sympathetic endings.
In the dog we have found no evidence for selective control of the release of
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noradrenaline or of adrenaline from the adrenal medulla. Our results are compatible
with those of previous workers on the dog (Malmejac, 1964; De Schaepdryver, 1959;
Wurtman, Casper, Pohorecky & Bartler, 1968) who failed to find evidence for
selective release from the adrenal medulla in response to physiological stimuli.
Having studied the reflex release of catecholamines in substantially similar
preparations in dogs and cats, we support the view that the controversy on selective
release can he resolved by the species difference in the control of the adrenal medulla
between dogs and cats. In the dog the ratio of noradrenaline to adrenaline does not
deviate from about 1:4 over a wide range of outputs. In the cat, on the other hand,
the resting output has a ratio of about 1:1, but when release is stimulated the
ratio can swing at least between 1:6 and 3:1.
The effect of hexamethonium bromide. We found the release of catecholamines in
response to baroreceptor stimulation in the cat to be abolished by hexamethonium
bromide at a dose that did not diminish similar responses to chemoreceptor stimula¬
tion. This finding may be relevant to the observation of Douglas & Poisner (1965),
in isolated cat adrenal glands, that noradrenaline is preferentially released by
nicotinic agonist drugs and adrenaline by muscarnic agonists. It also matches the
findings of Henderson & Ungar (1978) that reflex vasoconstriction in the hind limb
of the dog in response to baroreceptor tests is selectively inhibited by hexametho¬
nium bromide, and that to chemoreceptor tests by hyoscine methyl bromide. There
thus appear to be parallel nicotinic and non-nicotinic pathways both to chromaffin
cells and to sympathetic ganglia mediating baroreceptor and chemoreceptor reflexes
respectively.
We are grateful for the expert technical assistance of Mr P. H. Whelpdale. P. Ellis is an
M.R.C. Training Scholar.
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SUMMARY
1. The release of catecholamines from the adrenal medulla, in response to carotid
body hypoxia, may outlast the stimulus by more than 30 min.
2. After denervation of the adrenal gland the immediate release of catecholamines
in response to carotid hypoxia is abolished, but the prolonged release remains.
3. The prolonged release of catecholamines is abolished by cycloheximide.
4. Both corticotrophin in vivo and hydrocortisone in the isolated perfused adrenal
gland release adrenomedullary catecholamines.
5. It is concluded that a component of the response of the adrenal medulla to
carotid body hypoxia is mediated by corticotrophin and corticosteroid release.
INTRODUCTION
In previous work from this laboratory we studied the response of the adrenal
medulla to short hypoxic stimuli, localized to the carotid bifurcations, lasting
30—60 sec (Critchley, Ungar & Welburn, 1973; Critchley, 1976; Critchley, Ellis &
Ungar, 1980). We always found that the release of catecholamines began and ended
sharply with the beginning and end of the stimulus, as one would expect of a reflex
response mediated by the autonomic nervous system. We observed, however, that
if the stimulus was prolonged to 10 min, the release of catecholamines outlasted the
stimulus by at least a further 30 min, although both the adrenal glands and the
central nervous system remained perfused with well-oxygenated blood throughout
the experiment.
Carotid chemoreceptor stimulation releases corticotrophin from the anterior lobe
of the pituitary gland, and thus corticosteroids from the adrenal cortex (Anichkov,
Malyghina, Poskalenko & Ryzenkov, 1960; Marotta, 1972). The conversion of
noradrenaline to adrenaline in the mammalian chromaffin cell depends on the
induction of the enzyme phenylethanolamine A-methyl transferase (PNMT) by the
high concentration of corticosteroids that reaches the adrenal medulla through direct
portal channels from the cortex (Wurtman, Pohorecky & Baliga, 1972). Little is
known, however, of the influence of corticosteroids upon the release, as distinct from
the synthesis, of medullary catecholamines.
We have now investigated the possibility that the sustained release of catechol
amines in response to transient carotid hypoxia could be mediated by the pituitary-
adrenocortical axis.
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Preliminary reports of parts of this work have been published (Critchley & Ungar,
1974; Critchley, Henderson, Moffatt, Ungar, Waite & West, 1975).
METHODS
Anaesthesia, respiration, acid-base balance and temperature control
Dogs were anaesthetized with an i.v. injection of chloralose (55 mg/kg) and urethane
(550 mg/kg). Anaesthesia was maintained by a continuous l.v. infusion of the anaesthetic mixture
adjusted so as just to suppress the paw withdrawal reflex. The trachea was cannulated and
connected to a Starling 'Ideal' pump. The lungs were ventilated with a metered oxygen-nitrogen
mixture so as to hold l'.d C02 at 5 kPa and I'd 0i above 20 kPa, measured from frequent arterial
blood samples on a Radiometer BMS3 analyser. A molar solution of sodium bicarbonate was
injected when necessary to restore arterial plasma pH to 7 4. Body temperature was held near to
37 °C by a heating pad controlled from a rectal thermistor probe. Heparin (500 i.u./kg) was injected
after the completion of surgery. Dextran was infused if necessary to prevent the mean systemic
arterial pressure from falling below 75 mmHg.
Carotid perfusion
Both common carotid arteries were cannulated both ways, and blood from one was perfused into
both arteries towards the head by a Watson Marlow MHRE pump. The superior thyroid, internal
carotid and external carotid arteries and any other branches between the point of cannulation and
the origins of the lingual arteries, were ligated. The lingual arteries were left open to maintain an
adequate flow through the system and thus allow changes in the perfusing blood to affect the carotid
bodies quickly, but were occluded to test the vascular isolation of the carotid bifurcations. A
pressure transducer was connected to the perfusion circuit and linked through a servo amplifier to
the perfusion pump so that perfusion pressure could be held constant, or varied at will.
Stimulation of reflexes
Chemoreceptor tests were performed and evaluated as described by Henderson and Ungar (1978).
They consisted of a lowering of the of the perfusing blood by infusing into it a solution of sodium
dithionite (Critchley & Ungar, 1975). Carotid sinus pressure was held during chemoreceptor tests
at 150 or 140 mmHg. Baroreceptor tests were performed by lowering the carotid perfusion pressure
by 40 mmHg for 60 sec.
Both vagosympathetic trunks were divided in the neck to abolish secondary reflexes from
thoracic receptors. In two dogs the application of lignocaine (2 % solution) to both carotid sinus
nerves abolished the release of catecholamines, as well as the respiratory and cardiovascular
responses to chemoreceptor and baroreceptor tests.
Collection of adrenal venous blood and estimation of catecholamines
The left adrenolumbar vein was cannulated towards the gland, and the adrenal vein ligated
between the gland and the vena cava. The outflow was collected for timed periods in cooled tubes.
The concentrations of adrenaline and noradrenaline in the plasma were estimated fluorometrically,
after extraction on ion exchange columns, as described by Critchley et al (1980). By catecholamine
concentration, throughout this paper, we mean the sum of the concentrations of adrenaline and
noradrenaline, separately estimated. The fraction of adrenaline in the mixture did not vary in
resting or evoked releases outside the range of 75-80%. Replicate estimates of plasma containing
5 nM-catecholamine gave a standard deviation (s.d.) of 0-5 nM. The recovery of standards from
plasma was 90%.
Arterial concentrations of catecholamines during reflex responses did not exceed 2 x plasma
blanks.
Denervation of the left adrenal gland
The left splanchnic nerve was identified and cut about 30 mm from the adrenal gland. The
retroperitoneal connective tissue was dissected in an arc around the gland to interrupt additional
sympathetic fibres, particularly around the arteries supplying the gland. The abolition of the
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adrenal response to baroreceptor tests, while the pressor response remained, was taken as evidence
of complete denervation.
Isolated adrenal glands
Dogs, used for unrelated acute experiments, were anaesthetized and heparinized as above. Each
adrenolumbar vein was cannulated towards the gland, the adrenal vein tied between the gland and
the vena cava, and the gland excised leaving its arterial orifices open. The gland was Hushed through
with Locke's solution (Na+, 156 mM; K+, 56 mM; Ca2+, 4-3 mM; Cl_, 164 mM; HC03~ 1*8 mM;
glucose 5 m>i) and suspended by its cannula from a Langendorff isolated heart perfusion apparatus,
perfused with Locke's solution at 37 °C at a constant flow of 2 ml./min.
The effluent from the arterial orifices was collected for 30 sec periods in glass tubes in a L'nieam
AC'60 autoanalyser, which delivered the reagents for catecholamine assay, without the preliminary
extraction as for plasma.
Drugs
Chloralose, (BDH); corticotrophin, (Ciba); cycloheximide, (Sigma); heparin, (Evans); hydro¬
cortisone, (Glaxo); urethane, (BDH).
results
Resting output of catecholamines in dogs with innervated adrenal glands
In twenty-two dogs the mean resting output ofcatecholamines from the left adrenal
gland was 57 p-mole/min . kg, with a s.d. of 20. In those dogs which did not undergo
irreversible procedures, such as denervation, the resting levels remained stable over
the duration of the experiment; over a period of 90 min the s.d. of the output did
not exceed 25% of the resting output .
Chemoreceptor tests in dogs with innervated adrenal glands
In each of six dogs a baroreceptor test, lasting 1 min, and 10 min later a
chemoreceptor test, of 10 min duration, were performed. The mean output of
catecholamines in the course of these tests is shown in the top panel of Fig. 1. In each
test a rapid response was followed by a sustained output of catecholamines which
outlasted the stimulus by 20-60 min. During these tests the mean systemic blood
pressure rose from 73 + 8 to 105±20 mmHg.
Chemoreceptor tests in dogs with denervated adrenal glands
A secretory response which outlasts the stimulus that evoked it by more than a
few minutes is more likely to be mediated by a humoral than by a neural mechanism.
The crucial test of such a hypothesis is to divide the motor nerves supplying the
effector organ.
In six dogs with denervated left adrenal glands, baroreceptor tests lasting 1 min
were performed to confirm the total denervation of the gland. Ten minutes later
chemoreceptor tests, lasting 20 min, were performed. The mean results are shown
in the middle panel of Fig. 1. The output of catecholamines did not rise during the
baroreceptor test, although the usual reflex rise in systemic blood pressure was
seen. All the denervated glands responded to chemoreceptor tests with a rise in
catecholamine output but, in contrast to the response of innervated glands, a rise
was not seen during the first 5 min of a test. The time; course of a single response is
shown in Fig. 2.
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Chemoreceptor tests in dogs with fully isolated carotid bifurcations
In three dogs the lingual arteries were cannulated, completing the vascular
isolation of the carotid bifurcations, and blood was returned through a resistance to
a femoral vein. Two of the dogs had denervated left adrenal glands. They gave no
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Fig. 1. Responses ofdogs to baroreceptor and chemoreceptor tests. Mean responses of three
groups of six dogs. The columns represent the output of catecholamines from the left
adrenal gland (CA output). In each panel column A is the resting output, B the output
during a baroreceptor test, C the output 5 min after the start of a chemoreceptor test,
I) the output 10 min after the end of a chemoreceptor test and E the output 20 min after
the end of a chemoreceptor test. The vertical bars represent the s.e. of the mean output
in A and of the mean increment above resting level (hatched) in B-E. The top panel shows
the response of untreated dogs. In the chemoreceptor tests, the f'o, of the carotid perfusate
was reduced from 15+ 1 to 5 + 0-2 kPa for 10 min. The middle panel shows the responses
of dogs with denervated left adrenal glands. In the chemoreceptor tests, the PQl of the
carotid perfusate was reduced from 18 + 2 to 5 + 0-2 kPa for 20 min. The bottom panel
shows the responses of dogs given cycloheximide 50 rng/kg, 20 min before the test. In
the chemoreceptor tests, the l'0l of the carotid perfusate was reduced from 16 + 3 to
4 + 0-3 kPa.
catecholamine output rose to 3 x and 4 x the resting output 20 min after the end
of the chemoreceptor stimulus. The third dog, whose adrenal innervation was intact,
showed a 3 x increase in output in a baroreceptor test, and 4 x increases in output
both during and 20 min after the chemoreceptor test.
The patterns of these responses are identical with those of dogs having open lingual
arteries, and thus exclude the possibility that any part of the responses could be
mediated by structures reached directly by lingual arterial blood.
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The effect of cycloheximide on the responses of innervated glands to chemoreceptor and
baroreceptor tests
Cycloheximide is a drug which inhibits the release of corticosteroids in response
to corticotrophin (Garren, Ney & Davis, 1965). We performed tests before and after
the i.v. injection of cycloheximide (50 mg/kg) in six dogs. The results are shown
in the bottom panel of Fig. 1. The immediate release of catecholamines during both
Time (min)
Fig. 2. The time course of the responses to chemoreceptor tests and to corticotrophin. Time
course of the output ofcatecholamines (CA output) from the denervated left adrenal glands
of two dogs. Circles indicate the response to a chemoreceptor test lasting 20 min and
squares the response to an infusion of corticotrophin 25 fig over 20 min.
chemoreceptor and baroreceptor tests was not impaired by cycloheximide. In all six
dogs, however, the sustained release in response to the chemoreceptor tests was
abolished by cycloheximide.
These results support the idea of there being two components to the chemoreceptor
response, of which the late component is abolished by cycloheximide.
The effect of exogenous corticotrophin on adrenomedullary catecholamine output in vivo
In six dogs corticotrophin (25 jug) was infused intravenously. The mean results are
shown in Fig. 3 and the time course of a single response in Fig. 2. In two of these
dogs regular baroreceptor tests were performed before and after the administration
of corticotrophin. The release of catecholamines during baroreceptor stimulation was
potentiated 3-4-fold at the peak of the response to corticotrophin.
Corticotrophin increased the output of catecholamines with a similar time course
to that shown by prolonged chemoreceptor tests. At the peak of the action of
corticotrophin the response to baroreceptor tests was potentiated.
In three dogs corticotrophin (25 yg) was infused 50 min after the injection of
cycloheximide (50 mg/kg). The mean output of catecholamines rose from 21 +12
p-mole/min. kg by a mean of 13 + 5 p-mole/min. kg. This can be compared with
538 J.A.J. H. CRITCHLEY AND OTHERS
the rise in dogs untreated with cycloheximide, from a mean of86+16 p-mole/min. kg
by a mean of 216 + 76 p-mole/min . kg.
The release of catecholamines by hydrocortisone from isolated perfused adrenal glands
Seven isolated adrenal glands were perfused. Hydrocortisone was added to each
perfusate at concentrations of 30, 50 and 100 /ig/ml. for 5 min periods. The effect
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Fig. 3. The response of the adrenal medulla to corticotrophin. Mean output of catechol¬
amines from the left adrenal glands of six dogs (CA output). The bar indicates the
intravenous infusion of 25 yg corticotrophin. Vertical bars represent s.e.
of corticosteroid are within the physiological range for adrenal portal blood, if one
assumes that the adrenal blood flow was of the order of 1 % of the cardiac output.
The time course of the response to the middle dose of hydrocortisone is shown in
Fig. 4B. The time of onset of the release of catecholamines is similar to that of the
late component of the response to chemoreceptor tests, and to that of the response
to corticotrophin.
Three isolated adrenal glands were each perfused for 10 min with Locke's solution
containing cycloheximide (1 mg/ml.), a concentration far higher than that circulating
in the experiments in vivo. There was no change in the output of catecholamines.
DISCUSSION
We have previously reported (Critchley et al. 1980; Critchley, 1976) that in
baroreceptor and chemoreceptor tests lasting 1 min the output of catecholamines
from the left adrenal gland rose to between 2 x and 5 x the resting output. The output
invariably returned to or to below the resting level within 2 min after baroreceptor
tests, and within 5 min after chemoreceptor tests. The last figure is certainly an
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overestimate, because of the time taken to wash hypoxic blood out of the perfusion
system.
In the present experiments we used chemoreceptor tests lasting 10 or 20 min, and
the response was always sustained for 20-60 min after the end of the stimulus.
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Fig. 4. Responses of isolated adrenal glands to hydrocortisone. A, the mean resting output
of catecholamines (CA) from seven canine glands perfused with Locke's solution at
2 ml./min and 37 °C was 2-6 + 1-0 n-mole/min. The graph shows the incremented outputs
when the glands were exposed to three concentrations of hydrocortisone in the perfusate.
The vertical bars indicate standard deviations and the numbers of tests are shown in
brackets. B, the mean time course of the normalized output of catecholamines (CA output)
in response to the middle concentration of hydrocortisone shown in A, added to the
perfusate for 5 min as indicated by the horizontal bar.
output of catecholamines was greater. We were able to separate the response into
a fast and a slow phase. The fast phase, together with the baroreceptor response, was
abolished by denervation of the adrenal gland. The slow phase was abolished by
cycloheximide, and corresponded in its time course with the response to exogenous
corticotrophin.
We conclude from our results that there are two components to the response of
the adrenal medulla to arterial chemoreceptor stimulation. The rapid component
requires an intact nerve supply to the adrenal gland, but is independent of
adrenocortical function. The delayed component, on the other hand, requires an
intact pituitary-adrenocortical axis, but is independent of the motor nerves to the
gland.
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We were surprised to find no previous investigation of the direct effect of adreno¬
cortical function on the release of adrenal catecholamines, although their action on
the synthesis of adrenaline has been studied in detail. Wurtman, Casper, Pohorecky
& Bartter (1968) studied the release of adrenomedullary catecholamines in dogs in
response to insulin-hypoglycaemia. They compared the responses of normal dogs
Table 1. Insulin hypoglycaemia in normal dogs, hypophysectomized dogs, and hypophysectomized
dogs treated with corticotrophin
Resting output Peak response to insulin
(p-mole/min . kg) (p-mole/min . kg)
Nor- Nor¬
adrenaline Adrenaline Total adrenaline Adrenaline Total
Normal 8-6 405 49 1 37 8 172-3 2101
Hypophysectomized 140 22-7 36-7 51-3 84-2 1355
Hypophysectomized 16-7 38-9 556 174-4 401-8 576-2
-(-corticotrophin
Data recalculated from the results of Wurtman et al. (1968).
Resting output and peak stimulated output of adrenaline and noradrenaline from the adrenal
glands of five dogs.
with those of hypophysectomized dogs, and of hypophysectomized dogs treated with
corticotrophin. Their results were interpreted entirely with regard to changes induced
by corticosteroids in the synthesis of adrenaline, and are expressed as outputs and
percentages of adrenaline in adrenal venous plasma. In Table 1 we have recalculated
their data to show resting and evoked outputs of adrenaline and noradrenaline. It
is evident that corticotrophin increased the absolute output of noradrenaline, as well
as that ofadrenaline, in the resting state and particuarlyduring insulin hypoglycaemia.
Their results do not seem compatible with an action of corticosteroids solely on
adrenaline synthesis. They are more simply explained by an action on the release of
catecholamines, and suggest both direct release by steroids and the potentiation of
the effect of hypoglycaemia on the output of both amines. This action of corticotro¬
phin resembles the potentiation of the baroreceptor reflex that we have seen. There
could thus be two parallel actions of corticosteroids, one on synthesis and the other
on release. A further, and simpler, possibility, which seems to us to be compatible
with all the work reviewed by Wurtman et al. (1972), is that induction ofPNMT could
be secondary to release of adrenaline, as happens with dopamine /?-hydroxylase and
other synthetic enzymes. If in fact steroids do not act directly on release, but only
by the induction of synthesis, then it follows both from our results and from those
ofWurtman et al. (1968) that enhanced synthesis and overflow of noradrenaline must
be as important a part of the response as that of adrenaline.
In these experiments we have found that moderate hypoxia, with carotid arterial
PQ between 6-0 and 6-5 kPa was sufficient to evoke the release of catecholomines.
In previous experiments we found that a lower cartoid arterial PGi is needed to evoke
the immediate, presumably neural, release. This suggests that the humoral mechanism
may have a lower hypoxic threshold than the neural mechanism, and that it could
thus have the greater physiological importance.
ADRENAL CORTEX AND ADRENOMEDULLARY REFLEXES 541
We are grateful for the expert assistance of Mr P. H. Whelpdale. P. Ellis is an M.R.C. Training
Scholar.
REFERENCES
Anichkov. S. V.. Malyghina. E. I.. Poskalenko, A. N. & Ryzhenkov, V. E. (1960). Reflexes from
carotid bodies upon the adrenals. Archs int. Pharmacodyn. Ther. 129. 156-165.
Critchley. J. A. J. H. (1976). Reflex and neuroendocrine mechanisms of catecholamine release
from the adrenal medulla. Ph. D Thesis. Edinburgh University, Edinburgh.
Critchley. J. A. J. H.. Ellis, P. & Ungar, A. (1980). The reflex release ofadrenaline and noradren¬
aline from the adrenal glands of cats and dogs. J. Physiol. 298. 71-78.
Critchley. J. A. J. H.. Henderson. C. G.. Moffat, L. E. F., Ungar, A., Waite, J. & West,
Christine P. (1975). The release of catecholamines from perfused canine adrenal glands by
corticosteroids. J. Physiol. 254. 30-31P.
Critchley. J. A. J. H. & Ungar. A. (1974). Do the anterior pituitary and adrenal cortex
participate in the reflex response of the adrenal medulla to arterial hypoxia? J. Physiol. 239,
16-17P.
Critchley. J. A. J. H. & Ungar. A. (1975). A chemical method of lowering the PQi of blood in
experimental studies of arterial chemoreceptor reflexes. J. Physiol. 244. 12-13P.
Critchley. J. A. J. H.. Ungar, A. & Welburn, P.J. (1973). The release of adrenaline and
noradrenaline by the adrenal glands of cats and dogs in reflexes arising from the carotid
chemoreceptors and baroreceptors. J. Physiol. 234. 111-112P.
Henderson. C. G. & Ungar. A. (1978). Effect of cholinergic antagonistics on sympathetic
ganglionic transmission of vasomotor reflexes from the carotid baroreceptors and chemoreceptors
of the dog. J. Physiol. 277. 379-385.
Garren. L. D.. Xey. R. L. & Davis. W. W. (1965). Studies on the role of protein synthesis in the
regulation of corticosterone production by adrenocorticotrophic hormone in vivo. Proc. natn.
Acad. Sci. U.S.A. 53, 1443-1450.
Marotta. S. F. (1972). Comparative effects of hypoxia, adrenocorticotrophin and methylcholine
on adrenocortical secretory rates. Proc. Soc. exp. Biol. Med. 141, 923-927.
Wurtman. R. J.. Casper. A.. Pohorecky, L. A. & Bartter, F. C. (1968). Impaired secretion of
epinephrine in response to insulin among hypophysectomized dogs. Proc. natn. Acad. Sci. U.S.A.
61. 522-528.
Wfrtman. R. J.. Pohorecky, L. A. & Baliga, B. S. (1972). Adrenocortical control of the
biosynthesis of epinephrine and proteins in the adrenal medulla. Pharmac. Rev. 24, 411-426.
